
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link rel="preconnect" href="https://www.googletagmanager.com">
<link rel="dns-prefetch" href="https://www.google-analytics.com">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Pulmonary Embolism (PE) - Pulmonary Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "04bdb331-74e7-4552-b984-0e863fc6c2cd";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v915335";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "9e24a5a9-13df-489c-9594-33ec6a8c89f3",
 VasontId : "v915319"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "7e7f2d93-af3c-436c-895e-66a03e20f65b",
 VasontId : "v878832"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="04bdb331-74e7-4552-b984-0e863fc6c2cd">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = '27754a81-94d5-4428-93ed-0a280909bf8c';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Pulmonary Embolism (PE)
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/bull-todd.html">Todd M. Bull</a></strong>
 <p class="topic__authors--description">, MD, University of Colorado, Pulmonary and Critical Care;</p>
 <br>
 <strong class="topic__label topic__label--author"><a href="./Contributors/hountras-peter.html">Peter Hountras</a></strong>
 <p class="topic__authors--description">, MD, University of Colorado</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Jul 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="415.1" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v915343" class="topicmenu_mobile__paragraph">Etiology</a>
 </li>
 <li>
 <a href="#v915432" class="topicmenu_mobile__paragraph">Pathophysiology</a>
 </li>
 <li>
 <a href="#v915480" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v915486" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v915660" class="topicmenu_mobile__paragraph">General Treatment</a>
 </li>
 <li>
 <a href="#v14464105" class="topicmenu_mobile__paragraph">Anticoagulation</a>
 </li>
 <li>
 <a href="#v14464374" class="topicmenu_mobile__paragraph">Rapid Reduction of Clot Burden</a>
 </li>
 <li>
 <a href="#v915657" class="topicmenu_mobile__paragraph">Prognosis</a>
 </li>
 <li>
 <a href="#v14464461" class="topicmenu_mobile__paragraph">Prevention</a>
 </li>
 <li>
 <a href="#v14464867" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 <li>
 <a href="#v14464880" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Calculators'); }, keypress: function() { $data.activateGroup('Calculators'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Calculators (2)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="A-a Gradient">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 A-a Gradient
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/AAGradient.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"2c1be627-0c9e-46e8-8bb5-846973392a1e","Title":"A-a%20Gradient","ShareUrlTitle":"a-a-gradient","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"A-a%20Gradient","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="PE Probability: Wells Score System">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 PE Probability: Wells Score...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/PulmonaryEmbRisk.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"61827894-e12b-47d3-b357-59b1839cee23","Title":"PE%20Probability%3A%20Wells%20Score%20System","ShareUrlTitle":"pe-probability-wells-score-system","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"PE%20Probability%3A%20Wells%20Score%20System","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Images (3)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="An ECG in Pulmonary Embolism">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/p/u/l/pul_ecg_pul_embolism.gif?mw=350&amp;thn=0&amp;sc_lang=en" width="595" height="302" loading="lazy">
 </div>
 <span class="hero__description">
 An ECG in Pulmonary Embolism
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"An ECG in Pulmonary Embolism","Credits":"","IsRestricted":false,"ItemId":"1b395909-ae0d-42c9-a5eb-73a53cc42380","Title":"An%20ECG%20in%20Pulmonary%20Embolism","ShareUrlTitle":"an-ecg-in-pulmonary-embolism","Description":"%3Cp%3EThe%20ECG%20shows%20sinus%20tachycardia%20at%20a%20rate%20of%20110%20beats%2Fminute%2C%20an%20S1Q3T3%20and%20R%20%3D%20S%20in%20V1%20in%20a%20patient%20with%20proven%20acute%20pulmonary%20embolism.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/p/u/l/pul_ecg_pul_embolism.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/p/u/l/pul_ecg_pul_embolism.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"PUL_ECG_PUL_embolism.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"595","ImageHeight":"302","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"An%20ECG%20in%20Pulmonary%20Embolism","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Pulmonary Embolism (Chest CTA)">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="365" loading="lazy">
 </div>
 <span class="hero__description">
 Pulmonary Embolism (Chest CTA)
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Pulmonary Embolism (Chest CTA)","Credits":"\u003cspan id=\u0022v85661163\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Victor F. Tapson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"b3fd53f4-299a-4b4a-bcab-b8711598fcfc","Title":"Pulmonary%20Embolism%20%28Chest%20CTA%29","ShareUrlTitle":"pulmonary-embolism-chest-cta","Description":"%3Cp%3EThe%20images%20show%20bilateral%20pulmonary%20embolism%20on%20chest%20computed%20tomographic%20angiography.%20The%20arrows%20point%20to%20the%20filling%20defects%20%28emboli%29.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v54079685","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"365","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Pulmonary%20Embolism%20%28Chest%20CTA%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Pulmonary Embolism (Ventilation-Perfusion Scan)">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/v/p/s/vp-scan-tapson-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="630" loading="lazy">
 </div>
 <span class="hero__description">
 Pulmonary Embolism (Ventilation-P...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Pulmonary Embolism (Ventilation-Perfusion Scan)","Credits":"\u003cspan id=\u0022v85661182\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Victor F. Tapson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"ebc9261e-50f6-4cf0-9be0-49ef407158df","Title":"Pulmonary%20Embolism%20%28Ventilation-Perfusion%20Scan%29","ShareUrlTitle":"pulmonary-embolism-ventilation-perfusion-scan","Description":"%3Cp%3EThe%20ventilation-perfusion%20scan%20demonstrates%20high%20probability%20for%20acute%20pulmonary%20embolism.%20The%20ventilation%20is%20relatively%20unaffected%2C%20while%20the%20perfusion%20images%20show%20large%20defects%2C%20particularly%20in%20the%20left%20lung.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/v/p/s/vp-scan-tapson-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/v/p/s/vp-scan-tapson-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v54079702","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"630","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Pulmonary%20Embolism%20%28Ventilation-Perfusion%20Scan%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (4)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Risk Factors for Deep Venous...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"50f9ab06-63b4-44b8-8523-70fef34c765d","Title":"Risk%20Factors%20for%20Deep%20Venous%20Thrombosis%20and%20Pulmonary%20Embolism","ShareUrlTitle":"risk-factors-for-deep-venous-thrombosis-and-pulmonary-embolism","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610056","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Risk%20Factors%20for%20Deep%20Venous%20Thrombosis%20and%20Pulmonary%20Embolism","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Oral Anticoagulants">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Oral Anticoagulants
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"b71ae740-c406-45d3-b8e5-e105cd9df3ff","Title":"Oral%20Anticoagulants","ShareUrlTitle":"oral-anticoagulants","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610275","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Oral%20Anticoagulants","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Risk Assessment for Thrombosis">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Risk Assessment for Thrombosis
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"4fb2e44f-e9d1-4df1-af1b-935f914d961a","Title":"Risk%20Assessment%20for%20Thrombosis","ShareUrlTitle":"risk-assessment-for-thrombosis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610370","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Risk%20Assessment%20for%20Thrombosis","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Prophylaxis Based on Caprini Score">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Prophylaxis Based on Caprini...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"d0caedbe-74d1-41a3-bc57-f735a532f047","Title":"Prophylaxis%20Based%20on%20Caprini%20Score","ShareUrlTitle":"prophylaxis-based-on-caprini-score","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610625","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Prophylaxis%20Based%20on%20Caprini%20Score","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v915340" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are conditions that impair venous return, conditions that cause endothelial injury or dysfunction, and underlying hypercoagulable states. Symptoms of pulmonary embolism are nonspecific and include dyspnea, pleuritic chest pain, and, in more severe cases, light-headedness, presyncope, syncope, or cardiorespiratory arrest. Signs are also nonspecific and may include tachypnea, tachycardia, and in more severe cases, hypotension. Diagnosis of pulmonary embolism is most commonly accomplished with CT angiography, although ventilation perfusion scanning is sometimes required. Pulmonary embolism treatment is with anticoagulants and, sometimes, clot dissolution with systemic or catheter-directed thrombolysis or by removal of the clot via catheter suction thrombectomy or surgical resection. When anticoagulation is contraindicated, an inferior vena caval (IVC) filter can be considered until anticoagulation is resumed. Preventive measures include early mobilization, anticoagulants, and, in patients who are hospitalized, sometimes mechanical compression devices that are applied to the legs. </div></p></div><span id="v54079731" class="anchor"></span><div class="para"> <p>(See also <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31504429/">European Society of Cardiology 2019 Guidelines on Diagnosis and Management of Pulmonary Embolism</a> and <a rel="nofollow" target="_blank" href="https://ashpublications.org/bloodadvances/article/4/19/4693/463998/American-Society-of-Hematology-2020-guidelines-for">American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism</a>.)</p></div><span id="v14463921" class="anchor"></span><div class="para"> <p>The estimated annual incidence of pulmonary embolism world wide is approximately 1 per 1000 people (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363758" data-toggle="tooltip" title="General references" data-id="4e815201-78ad-4e55-8bf7-91bda576cde6" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="4e815201-78ad-4e55-8bf7-91bda576cde6" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363758"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="General references" loading="lazy"> </span> </a> </span> </span>). Up to 20% of people diagnosed with acute PE die in the next 90 days (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363758" data-toggle="tooltip" title="General references" data-id="4d9488e3-2457-417c-95f3-0c43f6dd5e6b" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">2</a><span id="4d9488e3-2457-417c-95f3-0c43f6dd5e6b" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363758"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="General references" loading="lazy"> </span> </a> </span> </span>). However, the cause of death is usually not the PE itself but the underlying condition increasing the patients risk for PE. From 30 to 50% of patients who have a PE describe functional and exercise limitations up to a year after the event, which is referred to as the post PE syndrome (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363758" data-toggle="tooltip" title="General references" data-id="97553cf8-ca2a-4d3b-bca8-d5701f46d50f" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">3</a><span id="97553cf8-ca2a-4d3b-bca8-d5701f46d50f" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363758"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="General references" loading="lazy"> </span> </a> </span> </span>).</p></div> <section id="v82363757" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v82363758" class="anchor"></span> General references </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82363761" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35793208/">Kahn SR, de Wit K</a>. Pulmonary Embolism. <i>N Engl J Med</i> 2022;387(1):45-57. doi:10.1056/NEJMcp2116489</p></div></li><li class="topic__listitem"><span id="v82363764" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/29536465/">Lehnert P, Lange T, Møller CH, Olsen PS, Carlsen J</a>. Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality. <i>Thromb Haemost</i> 2018;118(3):539-546. doi:10.1160/TH17-08-0531</p></div></li><li class="topic__listitem"><span id="v82363767" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/27932051/">Kahn SR, Hirsch AM, Akaberi A, et al</a>. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study. <i>Chest</i> 2017;151(5):1058-1068. doi:10.1016/j.chest.2016.11.030</p></div></li></ul></div> </div> </section> <section id="v915343" class="topic__section FHead" itemprop="cause" itemscope="" itemtype="http://schema.org/MedicalCause"> <h2 id="Etiology_v915344" class="topic__header--section" data-originaltitle="Etiology"> <span id="v915344" class="anchor"></span> Etiology of Pulmonary Embolism </h2> <div class="topic__content"> <span id="v915345" class="anchor"></span><div class="para"> <p>Nearly all pulmonary emboli arise from thrombi in the veins of the legs or pelvis (<a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html" data-toggle="tooltip" title="Deep Venous Thrombosis (DVT)" data-id="ec7a0ff9-dd17-4d59-8e82-6294b8fe865a" data-itemid="40a030fa-c405-40db-867d-6853f28279be">deep venous thrombosis</a><span id="ec7a0ff9-dd17-4d59-8e82-6294b8fe865a" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Deep Venous Thrombosis (DVT) </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Deep Venous Thrombosis (DVT)" loading="lazy"> </span> </a> </span> </span>). Risk of embolization is higher with thrombi that reach the popliteal vein or above. Thromboemboli can also originate in arm veins or central veins of the chest (caused by central venous catheters or resulting from thoracic outlet syndromes).</p></div><span id="v54079733" class="anchor"></span><div class="para"> <p>Pulmonary embolism can also arise from <a href="./{1B50BA92-02A4-4CF7-A711-2B722138B371}.html" data-toggle="tooltip" title="Nonthrombotic Pulmonary Embolism" data-id="af3cf203-1c5c-4836-bfc7-b6947a34b9e6" data-itemid="1b50ba92-02a4-4cf7-a711-2b722138b371">nonthrombotic sources</a><span id="af3cf203-1c5c-4836-bfc7-b6947a34b9e6" class="d-none xref"> <span class="tooltip-container"> <a href="./{1B50BA92-02A4-4CF7-A711-2B722138B371}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Nonthrombotic Pulmonary Embolism </span> Nonthrombotic sources of pulmonary embolism include air, fat, amniotic fluid, infected material, foreign bodies, tumors, and orthopedic cement. Pulmonary embolism (PE) can arise from nonthrombotic... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (eg, embolism of air, amniotic fluid, fat, infected material, orthopedic cement, foreign body, tumor). </p></div><span id="v14463923" class="anchor"></span><div class="para"> <p>Risk factors for deep venous thrombosis and pulmonary embolism (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"50f9ab06-63b4-44b8-8523-70fef34c765d","Title":"Risk%20Factors%20for%20Deep%20Venous%20Thrombosis%20and%20Pulmonary%20Embolism","ShareUrlTitle":"risk-factors-for-deep-venous-thrombosis-and-pulmonary-embolism","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610056","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ERisk%20Factors%20for%20Deep%20Venous%20Thrombosis%20and%20Pulmonary%20Embolism%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>) are similar in children and adults and include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14463927" class="anchor"></span><div class="para"> <p>Conditions that impair venous return, including bed rest and confinement without walking</p></div></li><li class="topic__listitem"><span id="v14463929" class="anchor"></span><div class="para"> <p>Conditions that cause endothelial injury or dysfunction such as trauma or surgery</p></div></li><li class="topic__listitem"><span id="v14463931" class="anchor"></span><div class="para"> <p>Underlying hypercoagulable (thrombophilic) disorders such as cancer or <a href="./{AD5DD1B5-44FC-4A38-A5E5-C1215163B095}.html" data-toggle="tooltip" title="Overview of Thrombotic Disorders" data-id="c4d81cef-6c66-4184-95bb-c501459f5c82" data-itemid="ad5dd1b5-44fc-4a38-a5e5-c1215163b095">primary clotting disorders</a><span id="c4d81cef-6c66-4184-95bb-c501459f5c82" class="d-none xref"> <span class="tooltip-container"> <a href="./{AD5DD1B5-44FC-4A38-A5E5-C1215163B095}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Thrombotic Disorders </span> In healthy people, homeostatic balance exists between procoagulant (clotting) forces and anticoagulant and fibrinolytic forces. Numerous genetic, acquired, and environmental factors can tip... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li></ul></div><span id="v54079736" class="anchor"></span><div class="para"> <p> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html" data-toggle="tooltip" title="COVID-19" data-id="acd18d0a-fc9d-4958-b87e-a31c8652f492" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">COVID-19</a><span id="acd18d0a-fc9d-4958-b87e-a31c8652f492" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> COVID-19 </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> appears to be a risk factor for deep venous thrombosis and pulmonary embolism. Although part of the risk may be due to reduced mobility associated with illness, it is thought that SARS-CoV-2 infection is prothrombotic.</p></div> <span id="v915350"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v915358"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"50f9ab06-63b4-44b8-8523-70fef34c765d","Title":"Risk%20Factors%20for%20Deep%20Venous%20Thrombosis%20and%20Pulmonary%20Embolism","ShareUrlTitle":"risk-factors-for-deep-venous-thrombosis-and-pulmonary-embolism","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610056","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Risk%20Factors%20for%20Deep%20Venous%20Thrombosis%20and%20Pulmonary%20Embolism","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="50f9ab06-63b4-44b8-8523-70fef34c765d"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '50f9ab06-63b4-44b8-8523-70fef34c765d' }, async: true, success: function (data) { $('#50f9ab06-63b4-44b8-8523-70fef34c765d').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v915432" class="topic__section FHead"> <h2 id="Pathophysiology_v915433" class="topic__header--section" data-originaltitle="Pathophysiology"> <span id="v915433" class="anchor"></span> Pathophysiology of Pulmonary Embolism </h2> <div class="topic__content"> <span id="v915434" class="anchor"></span><div class="para"> <p>Once deep venous thrombosis develops, clots may dislodge and travel through the venous system and the right side of the heart to lodge in the pulmonary arteries, where they partially or completely occlude one or more vessels. The consequences depend on the size and number of emboli, the underlying condition of the lungs, how well the right ventricle (RV) is functioning, and the ability of the body’s intrinsic thrombolytic system to dissolve the clots. Death, when is does occur, is often due to right ventricular failure. </p></div><span id="v915435" class="anchor"></span><div class="para"> <p>Small emboli may have no acute physiologic effects and may begin to lyse immediately and resolve within hours or days. Larger emboli can cause a reflex increase in ventilation (tachypnea), hypoxemia due to ventilation/perfusion (V/Q) mismatch, low mixed venous oxygen content as a result of low cardiac output, <a href="./{F29127B5-43BC-4DD6-89A0-0A627AF9B62E}.html" data-toggle="tooltip" title="Atelectasis" data-id="530947a3-0490-4355-95c2-815b8ce96245" data-itemid="f29127b5-43bc-4dd6-89a0-0a627af9b62e">atelectasis</a><span id="530947a3-0490-4355-95c2-815b8ce96245" class="d-none xref"> <span class="tooltip-container"> <a href="./{F29127B5-43BC-4DD6-89A0-0A627AF9B62E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atelectasis </span> Atelectasis is collapse of lung tissue with loss of volume. Patients may have dyspnea or respiratory failure if atelectasis is extensive. They may also develop pneumonia. Atelectasis is usually... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/l/e/f/left-lung-atelectasis-coruh-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Atelectasis" loading="lazy"> </span> </a> </span> </span> due to alveolar hypocapnia and abnormalities in surfactant, and an increase in pulmonary vascular resistance caused by mechanical obstruction and vasoconstriction resulting in tachycardia and hypotension. Endogenous lysis reduces most emboli, even those of moderate size, and physiologic alterations decrease over hours or days. Some emboli resist lysis and may organize and persist and sometimes cause chronic thromboembolic pulmonary hypertension (CTEPH). </p></div><span id="v14463991" class="anchor"></span><div class="para"> <p>Pulmonary emboli may be classified according to the physiologic effects as described by the European Society of Cardiology/American Heart Association (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363774" data-toggle="tooltip" title="Pathophysiology reference" data-id="a3ddb14a-91bf-4252-b7d1-b643c7f65395" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="a3ddb14a-91bf-4252-b7d1-b643c7f65395" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363774"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology reference </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology reference" loading="lazy"> </span> </a> </span> </span>) into the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v54079758" class="anchor"></span><div class="para"> <p>High risk (massive): Impaired right ventricular function causing hypotension, as defined by systolic blood pressure < 90 mm Hg or a drop in systolic blood pressure of ≥ 40 mm Hg from baseline for a period of 15 minutes</p></div></li><li class="topic__listitem"><span id="v14463996" class="anchor"></span><div class="para"> <p>Intermediate risk (submassive): Impaired right ventricular function without hypotension. This is evidenced by right ventricular enlargement and/or hypokinesis on imaging (eg, CT angiography, echocardiography) as well as by increases in circulating biomarkers (eg, troponin, brain natriuretic peptide). Note that the European Society of Cardiology defines intermediate-risk pulmonary embolism also as patients with a simplified pulmonary embolism severity index (sPESI) of > 0, thus including patients with other disorders or findings (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363774" data-toggle="tooltip" title="Pathophysiology reference" data-id="bf839b0f-45ed-4b64-afe0-aff42273c743" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="bf839b0f-45ed-4b64-afe0-aff42273c743" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363774"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology reference </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology reference" loading="lazy"> </span> </a> </span> </span>). Intermediate-risk pulmonary embolism can be further divided into intermediate high risk (the presence of right ventricular dysfunction by imaging <b>and</b> elevated circulating biomarkers) versus intermediate low risk (the presence of right ventricular dysfunction by imaging <b>or</b> circulating biomarker elevation). </p></div></li><li class="topic__listitem"><span id="v14463998" class="anchor"></span><div class="para"> <p>Low risk: Absence of right ventricular impairment and absence of hypotension (and by European Society of Cardiology, sPESI score = 0)</p></div></li></ul></div><span id="v14463999" class="anchor"></span><div class="para"> <p><b>Saddle pulmonary embolism</b> describes a pulmonary embolus that lodges in the bifurcation of the main pulmonary artery and into the right and left pulmonary arteries; saddle emboli are usually, but not always, intermediate risk or high risk. A saddle configuration does not dictate a specific therapeutic approach. Although saddle emboli are often large, causing near-complete or complete obstruction, they may also be a relatively thin, nonobstructive embolus.</p></div><span id="v14464000" class="anchor"></span><div class="para"> <p>In 1 to 3% of cases, chronic residual obstruction leads to <a href="./{B037D32C-CBB5-4ED3-9D6B-1D47D9F9B21F}.html" data-toggle="tooltip" title="Pulmonary Hypertension" data-id="3c5b5efe-40be-4738-9312-e0eb23dd4307" data-itemid="b037d32c-cbb5-4ed3-9d6b-1d47d9f9b21f">pulmonary hypertension</a><span id="3c5b5efe-40be-4738-9312-e0eb23dd4307" class="d-none xref"> <span class="tooltip-container"> <a href="./{B037D32C-CBB5-4ED3-9D6B-1D47D9F9B21F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Pulmonary Hypertension </span> Pulmonary hypertension is increased pressure in the pulmonary circulation. It has many secondary causes; some cases are idiopathic. In pulmonary hypertension, pulmonary vessels may become constricted... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (chronic thromboembolic pulmonary hypertension) that evolves over months to years and can result in chronic right heart failure. </p></div><span id="v14464003" class="anchor"></span><div class="para"> <p>When a large embolus acutely occludes major pulmonary arteries or when many smaller emboli combine to occlude a significant proportion of the more distal vessels, RV pressure increases, which may lead to <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html#v935920" data-toggle="tooltip" title="RV failure" data-id="02eddc51-b4f8-4a5a-856c-0f4ae91bbb5f" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">acute RV failure</a><span id="02eddc51-b4f8-4a5a-856c-0f4ae91bbb5f" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html#v935920"> <span class="tooltip-content"> <span class="tooltip-heading"> RV failure </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="RV failure" loading="lazy"> </span> </a> </span> </span>, shock, or sudden death. The risk of death depends on the degree and rate of rise of right-sided pressures and on the patient’s underlying cardiopulmonary status. Patients with preexisting cardiopulmonary disease are at higher risk of death, but young and/or otherwise healthy patients may survive a PE that occludes > 50% of the pulmonary bed. </p></div><span id="v915437" class="anchor"></span><div class="para"> <p>Pulmonary infarction (interruption of pulmonary artery blood flow leading to ischemia of lung tissue, sometimes represented by a pleural-based [peripherally located], often wedge-shaped pattern on chest x-ray [Hampton hump] or other imaging modalities) occurs in <span class='symbol'>&lt</span> 10% of patients diagnosed with PE. This low rate has been attributed to the dual blood supply to the lung (ie, bronchial and pulmonary). Generally, pulmonary infarction is due to smaller emboli that become lodged in more distal pulmonary arteries and is nearly always completely reversible; pulmonary infarction is recognized early, often before necrosis occurs. </p></div> <section id="v82363773" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v915433_v82363774" class="topic__header--subsection"> <span id="v82363774" class="anchor"></span> Pathophysiology reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82363777" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31504429/">Konstantinides SV, Meyer G, Becattini C, et al</a>: 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). <i>Eur Heart J</i> 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405</p></div></li></ul></div> </div> </section> </div> </section> <section id="v915480" class="topic__section FHead" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <h2 id="SymptomsAndSigns_v915481" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v915481" class="anchor"></span> Symptoms and Signs of Pulmonary Embolism </h2> <div class="topic__content"> <span id="v915482" class="anchor"></span><div class="para"> <p>Many pulmonary emboli are small, physiologically insignificant, and asymptomatic. Even when present, symptoms are nonspecific and vary in frequency and intensity, depending on the extent of pulmonary vascular occlusion and preexisting cardiopulmonary function.</p></div><span id="v915483" class="anchor"></span><div class="para"> <p>Emboli often cause </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464007" class="anchor"></span><div class="para"> <p>Acute dyspnea</p></div></li><li class="topic__listitem"><span id="v14464009" class="anchor"></span><div class="para"> <p>Pleuritic chest pain (when there is pulmonary infarction)</p></div></li></ul></div><span id="v14464010" class="anchor"></span><div class="para"> <p>Dyspnea may be minimal at rest and can worsen during activity.</p></div><span id="v14464011" class="anchor"></span><div class="para"> <p>Less common symptoms include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464014" class="anchor"></span><div class="para"> <p>Cough (usually caused by comorbid disorders or by dilation of the pulmonary arteries)</p></div></li><li class="topic__listitem"><span id="v14464016" class="anchor"></span><div class="para"> <p>Hemoptysis (occasionally occurs when there is pulmonary infarction)</p></div></li></ul></div><span id="v14464017" class="anchor"></span><div class="para"> <p>In older patients, the first symptom may be altered mental status.</p></div><span id="v14464018" class="anchor"></span><div class="para"> <p>Massive pulmonary emboli may manifest with hypotension, tachycardia, light-headedness/presyncope, syncope, or cardiac arrest.</p></div><span id="v915484" class="anchor"></span><div class="para"> <p>The most common signs of pulmonary embolism are </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464021" class="anchor"></span><div class="para"> <p>Tachycardia</p></div></li><li class="topic__listitem"><span id="v14464023" class="anchor"></span><div class="para"> <p>Tachypnea</p></div></li></ul></div><span id="v14464024" class="anchor"></span><div class="para"> <p>Less commonly, patients have hypotension. </p></div><span id="v82363779" class="anchor"></span><div class="para"> <p>A loud 2nd heart sound (S2) due to a loud pulmonic component (P2) is possible but uncommon in acute PE because increases in pulmonary artery pressures are only modest. Crackles or wheezing may occur, but these sounds are usually due to comorbid disease. In the presence of right ventricular failure, distended internal jugular veins and a RV heave may be evident, and a RV gallop (3rd heart sound [S3]), with or without tricuspid regurgitation, may be audible. </p></div><span id="v14464025" class="anchor"></span><div class="para"> <p>Fever, when present, is usually low-grade unless caused by an underlying condition.</p></div><span id="v915485" class="anchor"></span><div class="para"> <p>Pulmonary infarction is typically characterized by chest pain (mainly pleuritic) and, occasionally, hemoptysis. The chest wall may be tender.</p></div><span id="v14464026" class="anchor"></span><div class="para"> <p>Chronic thromboembolic pulmonary hypertension causes symptoms and signs of right heart failure, including exertional dyspnea, easy fatigue, and peripheral edema that develops over months to years.</p></div><span id="v14464027" class="anchor"></span><div class="para"> <p>Patients with acute pulmonary embolism may also have symptoms of <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html" data-toggle="tooltip" title="Deep Venous Thrombosis (DVT)" data-id="591f91ee-60d2-4644-ab6f-9625f412a998" data-itemid="40a030fa-c405-40db-867d-6853f28279be">deep venous thrombosis</a><span id="591f91ee-60d2-4644-ab6f-9625f412a998" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Deep Venous Thrombosis (DVT) </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Deep Venous Thrombosis (DVT)" loading="lazy"> </span> </a> </span> </span> (ie, pain, swelling, and/or erythema of a leg or an arm). Such leg symptoms are often not present, however.</p></div> </div> </section> <section id="v915486" class="topic__section FHead"> <h2 id="Diagnosis_v915487" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v915487" class="anchor"></span> Diagnosis of Pulmonary Embolism </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v915491" class="anchor"></span><div class="para"> <p>High index of suspicion</p></div></li><li class="topic__listitem"><span id="v915493" class="anchor"></span><div class="para"> <p>Assessment of pretest probability (based on clinical findings, including pulse oximetry and chest x-ray)</p></div></li><li class="topic__listitem"><span id="v915495" class="anchor"></span><div class="para"> <p>Subsequent testing based on pretest probability</p></div></li></ul></div><span id="v915496" class="anchor"></span><div class="para"> <p>The diagnosis of pulmonary embolism is challenging because symptoms and signs are nonspecific and diagnostic tests are not 100% sensitive and specific. It is important to include PE in the differential diagnosis when nonspecific symptoms, such as dyspnea, pleuritic chest pain, hemoptysis, light-headedness, or syncope are encountered. Thus, PE should be considered in the differential diagnosis of patients suspected of having </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464031" class="anchor"></span><div class="para"> <p> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="121f771f-a6f4-44f7-811e-ad94a4203bad" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">Cardiac ischemia</a><span id="121f771f-a6f4-44f7-811e-ad94a4203bad" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v14464033" class="anchor"></span><div class="para"> <p> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="df36885c-5da5-4eef-9f34-fd8fb6fe7fcb" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">Heart failure</a><span id="df36885c-5da5-4eef-9f34-fd8fb6fe7fcb" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v14464035" class="anchor"></span><div class="para"> <p> <a href="./{ABC32073-47D9-40BE-AE70-2C663FFC0C96}.html#v28584818" data-toggle="tooltip" title="Acute exacerbations" data-id="001d1a1a-0ed9-4278-ab68-e8676e493528" data-itemid="abc32073-47d9-40be-ae70-2c663ffc0c96">Chronic obstructive pulmonary disease (COPD) exacerbation</a><span id="001d1a1a-0ed9-4278-ab68-e8676e493528" class="d-none xref"> <span class="tooltip-container"> <a href="./{ABC32073-47D9-40BE-AE70-2C663FFC0C96}.html#v28584818"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute exacerbations </span> Chronic obstructive pulmonary disease (COPD) is airflow limitation caused by an inflammatory response to inhaled toxins, often cigarette smoke. Alpha-1 antitrypsin deficiency and various occupational... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/o/p/copd_chest_xray_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute exacerbations" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v14464037" class="anchor"></span><div class="para"> <p> <a href="./{13B1E050-5E1A-4A7F-AEC7-FD857C67E7AE}.html" data-toggle="tooltip" title="Pneumothorax" data-id="bc646f76-9b60-4d41-99d9-143565f8db3d" data-itemid="13b1e050-5e1a-4a7f-aec7-fd857c67e7ae">Pneumothorax</a><span id="bc646f76-9b60-4d41-99d9-143565f8db3d" class="d-none xref"> <span class="tooltip-container"> <a href="./{13B1E050-5E1A-4A7F-AEC7-FD857C67E7AE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Pneumothorax </span> Pneumothorax is air in the pleural space causing partial or complete lung collapse. Pneumothorax can occur spontaneously or result from trauma or medical procedures. Diagnosis is based on clinical... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0217945_pneumothorax_x-ray_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pneumothorax" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v14464039" class="anchor"></span><div class="para"> <p> <a href="./{63F630F8-D52B-4B0A-98FE-7F9A16E975AA}.html" data-toggle="tooltip" title="Overview of Pneumonia" data-id="ae7b683c-c972-4588-97ff-9e89b99672b5" data-itemid="63f630f8-d52b-4b0a-98fe-7f9a16e975aa">Pneumonia</a><span id="ae7b683c-c972-4588-97ff-9e89b99672b5" class="d-none xref"> <span class="tooltip-container"> <a href="./{63F630F8-D52B-4B0A-98FE-7F9A16E975AA}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Pneumonia </span> Pneumonia is acute inflammation of the lungs caused by infection. Initial diagnosis is usually based on chest x-ray and clinical findings. Causes, symptoms, treatment, preventive measures, and... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v14464041" class="anchor"></span><div class="para"> <p> <a href="./{782B9C7A-5E19-4F74-8DFF-B01F4B34D529}.html" data-toggle="tooltip" title="Sepsis and Septic Shock" data-id="c3ef567a-66d8-4011-9b7e-a19aa1174a0c" data-itemid="782b9c7a-5e19-4f74-8dff-b01f4b34d529">Sepsis</a><span id="c3ef567a-66d8-4011-9b7e-a19aa1174a0c" class="d-none xref"> <span class="tooltip-container"> <a href="./{782B9C7A-5E19-4F74-8DFF-B01F4B34D529}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sepsis and Septic Shock </span> Sepsis is a clinical syndrome of life-threatening organ dysfunction caused by a dysregulated response to infection. In septic shock, there is critical reduction in tissue perfusion; acute failure... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v14464043" class="anchor"></span><div class="para"> <p> <a href="./{7BC15747-85EC-4626-B72A-56C6C28000B8}.html#v28580788" data-toggle="tooltip" title="Acute exacerbations" data-id="6842dd10-185d-4ebe-82bf-937151c35a6e" data-itemid="7bc15747-85ec-4626-b72a-56c6c28000b8">Acute chest syndrome</a><span id="6842dd10-185d-4ebe-82bf-937151c35a6e" class="d-none xref"> <span class="tooltip-container"> <a href="./{7BC15747-85EC-4626-B72A-56C6C28000B8}.html#v28580788"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute exacerbations </span> Sickle cell disease (a hemoglobinopathy) causes a chronic hemolytic anemia occurring almost exclusively in people with African ancestry. It is caused by homozygous inheritance of genes for hemoglobin... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/i/c/sickle_cells_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute exacerbations" loading="lazy"> </span> </a> </span> </span> (in patients with sickle cell disease)</p></div></li><li class="topic__listitem"><span id="v14464045" class="anchor"></span><div class="para"> <p> <a href="./{A065B898-A920-4199-9B84-4D2126F2906A}.html" data-toggle="tooltip" title="Acute Stress Disorder (ASD)" data-id="a7b4af30-12d6-46c7-ab7e-a9b06c618441" data-itemid="a065b898-a920-4199-9b84-4d2126f2906a">Acute anxiety</a><span id="a7b4af30-12d6-46c7-ab7e-a9b06c618441" class="d-none xref"> <span class="tooltip-container"> <a href="./{A065B898-A920-4199-9B84-4D2126F2906A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Stress Disorder (ASD) </span> Acute stress disorder is a brief period of intrusive recollections occurring within 4 weeks of witnessing or experiencing an overwhelming traumatic event. Diagnosis is based on clinical criteria... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> with hyperventilation</p></div></li></ul></div><span id="v14464046" class="anchor"></span><div class="para"> <p>Significant, unexplained tachycardia may be a clue. Pulmonary embolism also should be considered in any older patient with tachypnea and altered mental status. </p></div><span id="v915497" class="anchor"></span><div class="para"> <p>Initial evaluation should include pulse oximetry and chest x-ray. Electrocardiography (ECG), arterial blood gas (ABG) measurements, or both may help to exclude other diagnoses (eg, <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="c32da655-def7-4a7f-9780-e59653046179" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">acute myocardial infarction</a><span id="c32da655-def7-4a7f-9780-e59653046179" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v41430416" class="anchor"></span><div class="para"> <p>The <b>chest x-ray</b> usually is nonspecific but may show <a href="./{F29127B5-43BC-4DD6-89A0-0A627AF9B62E}.html" data-toggle="tooltip" title="Atelectasis" data-id="47b1f773-eeab-4f4b-aeaa-82b709bc9335" data-itemid="f29127b5-43bc-4dd6-89a0-0a627af9b62e">atelectasis</a><span id="47b1f773-eeab-4f4b-aeaa-82b709bc9335" class="d-none xref"> <span class="tooltip-container"> <a href="./{F29127B5-43BC-4DD6-89A0-0A627AF9B62E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atelectasis </span> Atelectasis is collapse of lung tissue with loss of volume. Patients may have dyspnea or respiratory failure if atelectasis is extensive. They may also develop pneumonia. Atelectasis is usually... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/l/e/f/left-lung-atelectasis-coruh-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Atelectasis" loading="lazy"> </span> </a> </span> </span>, focal infiltrates, an elevated hemidiaphragm, or a pleural effusion. The classic findings of focal loss of vascular markings (Westermark sign), a peripheral, wedge-shaped density arising from the pleura (Hampton hump), or enlargement of the right descending pulmonary artery are suggestive but uncommon (ie, insensitive) and have low specificity. Chest x-ray can also help exclude pneumonia. Pulmonary infarction due to pulmonary embolism may be mistaken for pneumonia.</p></div><span id="v915501" class="anchor"></span><div class="para"> <p><b>Pulse oximetry</b> provides a quick way to assess oxygenation; hypoxemia is one sign of PE, and it requires further evaluation. <b>Blood gas testing</b> should be considered, particularly for patients with dyspnea or tachypnea who do not have hypoxemia detected with pulse oximetry. <a href="./{E32F7CC5-AC40-4B9A-9B4A-34B6629410A0}.html#v912851" data-toggle="tooltip" title="Arterial Blood Gas (ABG) Sampling" data-id="b926246d-f67a-4457-b259-f839c1b1fc2b" data-itemid="e32f7cc5-ac40-4b9a-9b4a-34b6629410a0">Arterial blood gas measurement</a><span id="b926246d-f67a-4457-b259-f839c1b1fc2b" class="d-none xref"> <span class="tooltip-container"> <a href="./{E32F7CC5-AC40-4B9A-9B4A-34B6629410A0}.html#v912851"> <span class="tooltip-content"> <span class="tooltip-heading"> Arterial Blood Gas (ABG) Sampling </span> Gas exchange is measured through several means, including Diffusing capacity for carbon monoxide Pulse oximetry Arterial blood gas sampling The diffusing capacity for carbon monoxide (DLCO)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> may show an increased alveolar to arterial oxygen (A-a) difference (sometimes called A-a gradient) or hypocapnia. Pulse oximetry and blood gas testing are moderately sensitive for PE, but neither is specific. Oxygen saturation may be normal due to a small clot burden, or to compensatory hyperventilation; a very low partial pressure of carbon dioxide (PCO2) detected with an arterial blood gas measurement can confirm hyperventilation.</p></div><span id="v915504" class="anchor"></span><div class="para"> <p><b>ECG</b> most often shows tachycardia and various ST-T wave abnormalities, which are not specific for pulmonary embolism (see figure <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"Alt":"An ECG in Pulmonary Embolism","Credits":"","IsRestricted":false,"ItemId":"1b395909-ae0d-42c9-a5eb-73a53cc42380","Title":"An%20ECG%20in%20Pulmonary%20Embolism","ShareUrlTitle":"an-ecg-in-pulmonary-embolism","Description":"%3Cp%3EThe%20ECG%20shows%20sinus%20tachycardia%20at%20a%20rate%20of%20110%20beats%2Fminute%2C%20an%20S1Q3T3%20and%20R%20%3D%20S%20in%20V1%20in%20a%20patient%20with%20proven%20acute%20pulmonary%20embolism.%3C%2Fp%3E","ImageUrl":"/-/media/manual/professional/images/p/u/l/pul_ecg_pul_embolism.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"/-/media/manual/professional/images/p/u/l/pul_ecg_pul_embolism.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"PUL_ECG_PUL_embolism.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"595","ImageHeight":"302","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAn%20ECG%20in%20Pulmonary%20Embolism%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). An S1Q3T3 (S wave in lead I, Q wave in lead III, inverted T wave in lead III) or a new right bundle branch block may indicate the effect of abrupt rise in RV size affecting RV conduction pathways; these findings are moderately specific but insensitive, occurring in only about 5% of patients, although the findings occur in a higher percentage of patients with massive PE. Right axis deviation (R <span class='symbol'>></span> S in V1) and P-pulmonale may be present. T-wave inversion in leads V1 to V4 also occurs.</p></div> <span id="v915506"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--figure "> <div class="inlinebox__wrapper"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v915513"></span> <div class="FigureFullPage" id="v56251754"> <h3 class="title">An ECG in Pulmonary Embolism</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><span id="v56251761" class="anchor"></span><div class="para"> <p>The ECG shows sinus tachycardia at a rate of 110 beats/minute, an S1Q3T3 and R <span class='symbol'>=</span> S in V1 in a patient with proven acute pulmonary embolism.</p></div> <div class="inlinemedia__container"> <div class="inlinemedia__image--container"> <img oncontextmenu="return false;" data-mmanualobjecttype="Image" src="./~/media/manual/professional/images/p/u/l/pul_ecg_pul_embolism.gif?thn=0&sc_lang=en" alt="An ECG in Pulmonary Embolism" lang="" loading="lazy" height="302" width="595"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"An ECG in Pulmonary Embolism","Credits":"","IsRestricted":false,"ItemId":"1b395909-ae0d-42c9-a5eb-73a53cc42380","Title":"An%20ECG%20in%20Pulmonary%20Embolism","ShareUrlTitle":"an-ecg-in-pulmonary-embolism","Description":"%3Cp%3EThe%20ECG%20shows%20sinus%20tachycardia%20at%20a%20rate%20of%20110%20beats%2Fminute%2C%20an%20S1Q3T3%20and%20R%20%3D%20S%20in%20V1%20in%20a%20patient%20with%20proven%20acute%20pulmonary%20embolism.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/p/u/l/pul_ecg_pul_embolism.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/p/u/l/pul_ecg_pul_embolism.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"PUL_ECG_PUL_embolism.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"595","ImageHeight":"302","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"","LinkText":"An%20ECG%20in%20Pulmonary%20Embolism","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":true,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> </div> </div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: Figure --> </div> <div class="inlinemedia-component " data-ko-rebind="v26464537" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/AAGradient.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"2c1be627-0c9e-46e8-8bb5-846973392a1e","Title":"A-a Gradient","ShareUrlTitle":"a-a-gradient","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> <section id="v915516" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v915487_v915517" class="topic__header--subsection"> <span id="v915517" class="anchor"></span> Clinical probability </h3> <div class="topic__content"> <span id="v915518" class="anchor"></span><div class="para"> <p>Clinical probability of pulmonary embolism can be assessed by combining ECG and chest x-ray findings with findings from the history and physical examination. Clinical prediction scores, such as the Wells score or the revised Geneva score (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449" data-toggle="tooltip" title="Diagnosis references" data-id="389a84ff-b95e-4422-a895-ed72004e2cd0" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="389a84ff-b95e-4422-a895-ed72004e2cd0" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>), or the Pulmonary Embolism Rule-Out Criteria (PERC) rule, may aid clinicians in assessing the chance that acute pulmonary embolism is present. These prediction scores assign points to a variety of clinical factors, with cumulative scores corresponding to designations of the probability of PE before testing (pretest probability). For example, the Wells score result is classified as likely or unlikely for PE. Clinical probability scoring has been best studied in patients presenting to the emergency department.</p></div><span id="v41430420" class="anchor"></span><div class="para"> <p>One of the important clinical criteria is a judgment of whether PE is more likely than an alternate diagnosis, and this determination is somewhat subjective. However, the clinical judgment of experienced clinicians is as sensitive as, or even more sensitive than, results from formal prediction scores. PE should probably be considered more likely if one or more of the symptoms and signs, particularly dyspnea, hemoptysis, tachycardia, or hypoxemia, cannot be explained clinically or by chest x-ray results. </p></div><span id="v14464053" class="anchor"></span><div class="para"> <p>Pretest probability guides testing strategy and the interpretation of test results. In patients in whom the probability of PE is unlikely, only minimal additional testing (ie, D-dimer testing in outpatients) may be needed. In such cases, a negative D-dimer test (<span class='symbol'>&lt</span> 0.4 mcg/mL [<span class='symbol'>&lt</span> 2.2 nmol/L]) is highly indicative of the <i>absence</i> of pulmonary embolism. Conversely, if there is a high clinical suspicion of PE and the risk of bleeding is low, immediate anticoagulation should be considered while the diagnosis is confirmed with additional tests. </p></div><span id="v41430421" class="anchor"></span><div class="para"> <p>The PERC rule specifies 8 criteria. Presence of all these criteria in a patient who, based on clinical findings, is at low risk specifies that testing for PE is not indicated (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449" data-toggle="tooltip" title="Diagnosis references" data-id="cfa07102-daa2-4ebe-b967-4ec03b92809b" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">2</a><span id="cfa07102-daa2-4ebe-b967-4ec03b92809b" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>). The criteria are:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v41430424" class="anchor"></span><div class="para"> <p>Age < 50 years</p></div></li><li class="topic__listitem"><span id="v41430426" class="anchor"></span><div class="para"> <p>Heart rate < 100</p></div></li><li class="topic__listitem"><span id="v41430428" class="anchor"></span><div class="para"> <p>Oxygen saturation ≥ 95%</p></div></li><li class="topic__listitem"><span id="v41430430" class="anchor"></span><div class="para"> <p>No prior deep venous thrombosis or pulmonary embolism</p></div></li><li class="topic__listitem"><span id="v41430432" class="anchor"></span><div class="para"> <p>No unilateral leg swelling</p></div></li><li class="topic__listitem"><span id="v41430434" class="anchor"></span><div class="para"> <p>No <span class="genericDrug" data-showrollover="false">estrogen</span> use</p></div></li><li class="topic__listitem"><span id="v41430436" class="anchor"></span><div class="para"> <p>No hemoptysis</p></div></li><li class="topic__listitem"><span id="v41430438" class="anchor"></span><div class="para"> <p>No surgery or trauma requiring hospitalization within the past 4 weeks</p></div></li></ul></div><span id="v41430439" class="anchor"></span><div class="para"> <p>Use of the PERC rule has been recommended as a way to decrease rates of testing for PE with conventional testing using D-dimer, but with similar rates of sensitivity and negative predictive values.</p></div> <div class="inlinemedia-component " data-ko-rebind="v14464054" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/PulmonaryEmbRisk.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"61827894-e12b-47d3-b357-59b1839cee23","Title":"PE Probability: Wells Score System","ShareUrlTitle":"pe-probability-wells-score-system","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> </div> </section> <section id="v915520" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v915487_v915521" class="topic__header--subsection"> <span id="v915521" class="anchor"></span> Diagnostic testing </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464060" class="anchor"></span><div class="para"> <p>Screening of outpatients with D-dimer testing if pre-test probability is low or of intermediate probability</p></div></li><li class="topic__listitem"><span id="v14464062" class="anchor"></span><div class="para"> <p>If pretest probability is high or if D-dimer result is elevated, CT angiography, or if renal insufficiency is present or when CT contrast is contraindicated, with ventilation/perfusion (V/Q) scanning</p></div></li><li class="topic__listitem"><span id="v14464064" class="anchor"></span><div class="para"> <p>Sometimes ultrasonography of the legs or arms (to confirm deep venous thrombosis when lung imaging is delayed or prohibitive)</p></div></li></ul></div><span id="v915522" class="anchor"></span><div class="para"> <p>There is no universally accepted algorithm for the approach to suspected acute pulmonary embolism. Tests most useful for diagnosing or excluding PE are</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464067" class="anchor"></span><div class="para"> <p>D-dimer testing</p></div></li><li class="topic__listitem"><span id="v14464069" class="anchor"></span><div class="para"> <p>CT angiography</p></div></li><li class="topic__listitem"><span id="v14464071" class="anchor"></span><div class="para"> <p>Ventilation/perfusion scanning</p></div></li><li class="topic__listitem"><span id="v14464073" class="anchor"></span><div class="para"> <p>Duplex ultrasonography</p></div></li></ul></div><span id="v41430440" class="anchor"></span><div class="para"> <p>Echocardiography may be useful to identify pulmonary embolism on the way to the lung (clot-in-transit) or to find evidence of new right ventricular dysfunction. Echocardiographic findings that may suggest pulmonary embolism include the 60/60 sign, which is the combination of a pulmonary artery acceleration time of < 60 milliseconds with a peak systolic tricuspid valve gradient of < 60 mm Hg (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449" data-toggle="tooltip" title="Diagnosis references" data-id="4af6a3a8-65b3-4278-9822-448cc584410d" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">3</a><span id="4af6a3a8-65b3-4278-9822-448cc584410d" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>), and the McConnell sign, which is depressed contractility of the RV free wall compared to the RV apex (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449" data-toggle="tooltip" title="Diagnosis references" data-id="f6033786-b902-44f9-9285-e3e5e0b74fef" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">4</a><span id="f6033786-b902-44f9-9285-e3e5e0b74fef" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v915532" class="anchor"></span><div class="para"> <p><b>D-Dimer</b> is a by-product of intrinsic fibrinolysis; thus, elevated levels occur in the presence of a recent thrombus. Historically, when pretest probability is considered low or intermediate, a negative D-dimer level (<span class='symbol'>&lt</span> 0.4 mcg/mL [<span class='symbol'>&lt</span> 2.2 nmol/L]) is highly sensitive for the <i>absence</i> of PE with a negative predictive value of > 95%; in most cases, this result is sufficiently reliable for excluding the diagnosis of PE in the emergency department or clinic. More recently, data have shown that age can elevate D-dimer levels, which can cause a false-positive test result. Therefore, in patients with a low or intermediate pretest probability of PE and age over 50 years, the most common correction factor is to use a cutoff value of age multiplied by 10 in ng/mL. However, elevated D-dimer levels are not specific for venous thrombus because many patients without deep venous thrombosis (DVT) or PE also have elevated levels (particularly in patients who are hospitalized). Therefore, further testing is required when the D-dimer level is elevated or when the pretest probability for PE is high. </p></div><span id="v915540" class="anchor"></span><div class="para"> <p><b>CT angiography</b> is the preferred imaging technique for diagnosing acute pulmonary embolism. It is rapid, accurate, and highly sensitive and specific. It can also give more information about other lung pathology (eg, demonstration of pneumonia rather than PE as a cause of hypoxia or pleuritic chest pain) as well as severity of PE (for example by the size of the right ventricle or the reflux into the hepatic veins). Although poor quality scans due to motion artifact or poor contrast boluses can limit the sensitivity of the examination, CT technology now allows acquisition times of <span class='symbol'>&lt</span> 2 seconds, providing relatively motion-free images in patients with dyspnea. Fast scanning times allow the use of smaller volumes of iodinated contrast, which reduces the risk of acute kidney injury. </p></div> <div class="inlinemedia-component " data-ko-rebind="v54079685" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Pulmonary Embolism (Chest CTA)","Credits":"\u003cspan id=\u0022v85661163\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Victor F. Tapson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"b3fd53f4-299a-4b4a-bcab-b8711598fcfc","Title":"Pulmonary Embolism (Chest CTA)","ShareUrlTitle":"pulmonary-embolism-chest-cta","Description":"\u003cul\u003e\u003cspan id=\u0022v88813615\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThe images show bilateral pulmonary embolism on chest computed tomographic angiography. The arrows point to the filling defects (emboli).\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v54079685","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"365","IframeSrc":null,"Target":null}'> </div><span id="v14464074" class="anchor"></span><div class="para"> <p>The sensitivity of CT angiography is highest for pulmonary embolism in the main pulmonary artery or lobar or segmental vessels. Sensitivity of CT angiography is lowest for emboli in subsegmental vessels (about 30% of all pulmonary emboli). However, CT angiography is still the preferred means of diagnosing acute PE if there are no contraindications. </p></div><span id="v915534" class="anchor"></span><div class="para"> <p><b>Ventilation/perfusion (V/Q) scans</b> in pulmonary embolism detect areas of lung that are ventilated but not perfused. V/Q scanning takes longer than CT angiography and is less specific. However, when chest x-ray findings are normal or near normal and no significant underlying lung disease exists, it is a highly sensitive test. V/Q scanning is particularly useful when renal insufficiency precludes the use of contrast agents, which are otherwise required for CT angiography, and in pregnant patients (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449" data-toggle="tooltip" title="Diagnosis references" data-id="a74bb6f3-cb6c-40d8-8575-389ebca8b2b7" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">5</a><span id="a74bb6f3-cb6c-40d8-8575-389ebca8b2b7" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>). In some hospitals, V/Q scanning can be done with a portable machine that provides 3 views of ventilation and perfusion, which is useful when a patient is too ill to move. Perfusion defects may occur in many other lung conditions (eg, <a href="./{ABC32073-47D9-40BE-AE70-2C663FFC0C96}.html" data-toggle="tooltip" title="Chronic Obstructive Pulmonary Disease (COPD)" data-id="c7112fab-815e-48d3-aa6c-c71bb9114644" data-itemid="abc32073-47d9-40be-ae70-2c663ffc0c96">COPD</a><span id="c7112fab-815e-48d3-aa6c-c71bb9114644" class="d-none xref"> <span class="tooltip-container"> <a href="./{ABC32073-47D9-40BE-AE70-2C663FFC0C96}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Obstructive Pulmonary Disease (COPD) </span> Chronic obstructive pulmonary disease (COPD) is airflow limitation caused by an inflammatory response to inhaled toxins, often cigarette smoke. Alpha-1 antitrypsin deficiency and various occupational... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/o/p/copd_chest_xray_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Obstructive Pulmonary Disease (COPD)" loading="lazy"> </span> </a> </span> </span>, <a href="./{7B11302D-B158-4504-AB57-C93F84917D24}.html" data-toggle="tooltip" title="Idiopathic Pulmonary Fibrosis" data-id="30cd54e0-49d8-4581-b980-fd576597a69b" data-itemid="7b11302d-b158-4504-ab57-c93f84917d24">pulmonary fibrosis</a><span id="30cd54e0-49d8-4581-b980-fd576597a69b" class="d-none xref"> <span class="tooltip-container"> <a href="./{7B11302D-B158-4504-AB57-C93F84917D24}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Idiopathic Pulmonary Fibrosis </span> Idiopathic pulmonary fibrosis (IPF), the most common form of idiopathic interstitial pneumonia, causes progressive pulmonary fibrosis. Symptoms and signs develop over months to years and include... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/i/d/i/idiopathic_pulmonary_fibrosis_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Idiopathic Pulmonary Fibrosis" loading="lazy"> </span> </a> </span> </span>, <a href="./{63F630F8-D52B-4B0A-98FE-7F9A16E975AA}.html" data-toggle="tooltip" title="Overview of Pneumonia" data-id="268e7ba4-59f3-46cd-a36c-b69041ffd094" data-itemid="63f630f8-d52b-4b0a-98fe-7f9a16e975aa">pneumonia</a><span id="268e7ba4-59f3-46cd-a36c-b69041ffd094" class="d-none xref"> <span class="tooltip-container"> <a href="./{63F630F8-D52B-4B0A-98FE-7F9A16E975AA}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Pneumonia </span> Pneumonia is acute inflammation of the lungs caused by infection. Initial diagnosis is usually based on chest x-ray and clinical findings. Causes, symptoms, treatment, preventive measures, and... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{B58C6734-551E-48F9-BD3E-46833ABFB2FE}.html" data-toggle="tooltip" title="Pleural Effusion" data-id="b37b2e79-58b1-4f43-91c3-ad10e5b67f53" data-itemid="b58c6734-551e-48f9-bd3e-46833abfb2fe">pleural effusion</a><span id="b37b2e79-58b1-4f43-91c3-ad10e5b67f53" class="d-none xref"> <span class="tooltip-container"> <a href="./{B58C6734-551E-48F9-BD3E-46833ABFB2FE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Pleural Effusion </span> Pleural effusions are accumulations of fluid within the pleural space. They have multiple causes and are usually classified as transudates or exudates. Detection is by physical examination,... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/l/e/pleural_effusions_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pleural Effusion" loading="lazy"> </span> </a> </span> </span>). Mismatched perfusion defects that may mimic PE may occur in pulmonary vasculitis, pulmonary veno-occlusive disease, and <a href="./{285BEC0C-210A-4E80-992E-46E28833CE13}.html" data-toggle="tooltip" title="Sarcoidosis" data-id="7d429fbb-f5f1-4d03-9b23-f1603ff05b9e" data-itemid="285bec0c-210a-4e80-992e-46e28833ce13">sarcoidosis</a><span id="7d429fbb-f5f1-4d03-9b23-f1603ff05b9e" class="d-none xref"> <span class="tooltip-container"> <a href="./{285BEC0C-210A-4E80-992E-46E28833CE13}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sarcoidosis </span> Sarcoidosis is an inflammatory disorder resulting in noncaseating granulomas in one or more organs and tissues; etiology is unknown. The lungs and lymphatic system are most often affected, but... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/a/r/sarcoidosis-lung-histology-sah-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Sarcoidosis" loading="lazy"> </span> </a> </span> </span>.</p></div><span id="v54079766" class="anchor"></span><div class="para"> <p>Results are based on patterns of V/Q mismatch and typically are reported as</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v54079769" class="anchor"></span><div class="para"> <p>Normal: Excludes PE with nearly 100% accuracy</p></div></li><li class="topic__listitem"><span id="v54079771" class="anchor"></span><div class="para"> <p>Very low probability: < 5%</p></div></li><li class="topic__listitem"><span id="v54079773" class="anchor"></span><div class="para"> <p>Low probability: 15% likelihood of PE</p></div></li><li class="topic__listitem"><span id="v54079775" class="anchor"></span><div class="para"> <p>Intermediate probability: 30 to 40% probability of PE</p></div></li><li class="topic__listitem"><span id="v54079777" class="anchor"></span><div class="para"> <p>High probability: 80 to 90% probability of PE</p></div></li></ul></div><span id="v14464075" class="anchor"></span><div class="para"> <p>The results of clinical probability testing must be used together with the scan result to determine the need for treatment or further testing (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449" data-toggle="tooltip" title="Diagnosis references" data-id="ffd3fc16-dea8-46a7-a266-2814cd3d5799" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">6</a><span id="ffd3fc16-dea8-46a7-a266-2814cd3d5799" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430449"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>).</p></div> <div class="inlinemedia-component " data-ko-rebind="v54079702" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Pulmonary Embolism (Ventilation-Perfusion Scan)","Credits":"\u003cspan id=\u0022v85661182\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Victor F. Tapson, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"ebc9261e-50f6-4cf0-9be0-49ef407158df","Title":"Pulmonary Embolism (Ventilation-Perfusion Scan)","ShareUrlTitle":"pulmonary-embolism-ventilation-perfusion-scan","Description":"\u003cul\u003e\u003cspan id=\u0022v88813619\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThe ventilation-perfusion scan demonstrates high probability for acute pulmonary embolism. The ventilation is relatively unaffected, while the perfusion images show large defects, particularly in the left lung.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/v/p/s/vp-scan-tapson-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/v/p/s/vp-scan-tapson-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v54079702","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"630","IframeSrc":null,"Target":null}'> </div><span id="v915539" class="anchor"></span><div class="para"> <p><b>Duplex ultrasonography</b> is a safe, noninvasive, portable technique for detecting leg or arm thrombi. A clot can be detected by showing poor compressibility of the vein or by showing reduced flow by Doppler ultrasonography. The test has a sensitivity of <span class='symbol'>></span> 95% and a specificity of <span class='symbol'>></span> 95% for thrombus. Confirming DVT in the calf or iliac veins can be more difficult but can generally be accomplished. The ultrasound technician should always attempt to image below the popliteal vein into its trifurcation. </p></div><span id="v14464076" class="anchor"></span><div class="para"> <p>Absence of thrombi in the leg veins does not exclude the possibility of thrombus from other sources, such as the upper extremities or pelvic vasculature, but patients with suspected DVT and negative results on Doppler duplex ultrasonography have <span class='symbol'>></span> 95% event-free survival, because thrombi from other sources are so much less common. </p></div><span id="v14464077" class="anchor"></span><div class="para"> <p>Although ultrasonography of the legs or arms is not diagnostic for PE, a study that reveals leg or axillary-subclavian thrombus establishes the need for anticoagulation and may obviate the need for further diagnostic testing unless more aggressive therapy (eg, thrombolytic therapy) is being considered. Therefore, stopping the diagnostic evaluation after detection of DVT on ultrasonography of the legs or arms is most appropriate for stable patients with contraindications to CT contrast and in whom V/Q scanning is expected to have low specificity (eg, in patients with an abnormal chest x-ray). In suspected acute PE, a negative ultrasound does not negate the need for additional studies.</p></div> <a id="v14464078"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--pearlsandpitfalls "> <div class="inlinebox__wrapper" id="v14464080"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464080"></span> <div class="SidebarHalfPage" id="v56251763"> <h3 class="title">Pearls & Pitfalls</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56251772" class="anchor"></span><div class="para"> <p>In suspected acute pulmonary embolism, absence of venous thrombosis on ultrasonography does not rule out PE.</p></div></li></ul></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: PearlsAndPitfalls --> </div><span id="v915543" class="anchor"></span><div class="para"> <p><b>Echocardiography</b> may show a clot in the right atrium or ventricle, but echocardiography is most commonly used for risk stratification in acute PE. The presence of right ventricular dilation and hypokinesis may suggest the need for more aggressive therapy. </p></div><span id="v915545" class="anchor"></span><div class="para"> <p><b>Cardiac marker testing</b> is a useful means of stratifying mortality risk in patients with acute pulmonary embolism. Cardiac marker testing can be used as an adjunct to other testing if PE is suspected or proven. Elevated troponin levels signify right ventricular (or sometimes left ventricular) ischemia. Elevated brain natriuretic peptide (BNP) and pro-BNP levels may signify RV dysfunction; however, these tests are not specific for RV dysfunction or for PE.</p></div><span id="v915548" class="anchor"></span><div class="para"> <p><b>Thrombotic disorder (thrombophilia)</b> testing should not be done routinely. Testing should be considered for patients with unprovoked PE (ie, with no known risk factors or cause), especially if they are younger (age < 60 years), have recurrent PE, or have a positive family history. Certain thrombophilias, such as <a href="./{44CEDC40-68D1-4D39-B8AF-97CC5C64D120}.html" data-toggle="tooltip" title="Antiphospholipid Syndrome (APS)" data-id="d1526e35-289e-4d7b-b0ad-628d9e929449" data-itemid="44cedc40-68d1-4d39-b8af-97cc5c64d120">antiphospholipid syndrome</a><span id="d1526e35-289e-4d7b-b0ad-628d9e929449" class="d-none xref"> <span class="tooltip-container"> <a href="./{44CEDC40-68D1-4D39-B8AF-97CC5C64D120}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiphospholipid Syndrome (APS) </span> Antiphospholipid syndrome is an autoimmune disorder characterized by venous and arterial thrombosis or pregnancy complications (eg, recurrent miscarriage) and persistent autoantibodies to phospholipid-bound... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, require disease-specific types of anticoagulation therapy. <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html" data-toggle="tooltip" title="COVID-19" data-id="bb76a5d6-8d10-41c5-9d57-18c8eb20d4e0" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">SARS-CoV-2 infection</a><span id="bb76a5d6-8d10-41c5-9d57-18c8eb20d4e0" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> COVID-19 </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> should be considered in the appropriate clinical setting.</p></div><span id="v14464089" class="anchor"></span><div class="para"> <p><b>Pulmonary arteriography</b> is rarely needed to diagnose acute PE because noninvasive CT angiography has similar sensitivity and specificity. However, in patients in whom catheter-based thrombolytic therapy is being used, pulmonary angiography is useful for assessment of catheter placement and may be used as a rapid means of determining success of the procedure when the catheter is removed. Pulmonary arteriography is also used together with right-heart catheterization in assessing whether patients with chronic thromboembolic pulmonary hypertension are candidates for pulmonary endarterectomy.</p></div> </div> </section> <section id="v41430448" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v915487_v41430449" class="topic__header--subsection"> <span id="v41430449" class="anchor"></span> Diagnosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v41430452" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed?term=16461960">Le Gal G, Righini M, Roy PM, et al</a>: Prediction of pulmonary embolism in the emergency department: the revised Geneva score. <i>Ann Intern Med</i> 144:165–171, 2006.</p></div></li><li class="topic__listitem"><span id="v82363791" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/18318689/">Kline JA, Courtney DM, Kabrhel C, et al</a>. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. <i>J Thromb Haemost</i> 6(5):772-780, 2008. doi:10.1111/j.1538-7836.2008.02944.x</p></div></li><li class="topic__listitem"><span id="v82363794" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/12208411/">Kurzyna M, Torbicki A, Pruszczyk P, et al</a>: Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. <i>Am J Cardiol</i> 90(5):507–511, 2002. doi:10.1016/s0002-9149(02)02523-7</p></div></li><li class="topic__listitem"><span id="v82363797" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/8752195/">McConnell MV, Solomon SD, Rayan ME, et al</a>: Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. <i>Am J Cardiol</i> 78(4):469–473, 1996. doi:10.1016/s0002-9149(96)00339-6</p></div></li><li class="topic__listitem"><span id="v82363800" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/22086989/">Leung AN, Bull TM, Jaeschke R, et al</a>. An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. <i>Am J Respir Crit Care Med</i> 2011;184(10):1200-1208. doi:10.1164/rccm.201108-1575ST</p></div></li><li class="topic__listitem"><span id="v82363803" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/2332918/">PIOPED Investigators</a>: Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). <i>JAMA</i> 263(20):2753–2759, 1990. doi:10.1001/jama.1990.03440200057023</p></div></li></ul></div> </div> </section> </div> </section> <section id="v915660" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v915661" class="topic__header--section" data-originaltitle="General Treatment"> <span id="v915661" class="anchor"></span> General Treatment of Pulmonary Embolism </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v915665" class="anchor"></span><div class="para"> <p>Supportive therapy</p></div></li><li class="topic__listitem"><span id="v14464099" class="anchor"></span><div class="para"> <p>Anticoagulation</p></div></li><li class="topic__listitem"><span id="v915667" class="anchor"></span><div class="para"> <p>Inferior vena cava filter placement (rarely, in selected patients)</p></div></li><li class="topic__listitem"><span id="v915669" class="anchor"></span><div class="para"> <p>Rapid clot burden reduction via thrombolysis or embolectomy (in selected patients)</p></div></li></ul></div><span id="v14464100" class="anchor"></span><div class="para"> <p><b>Rapid assessment</b> for the need for supportive therapy should be undertaken. In patients with hypoxemia, oxygen should be given. In patients with hypotension due to massive PE, IV fluids should be administered as boluses, paying close attention to effect and volume status. Caution is warranted because overloading the right ventricle can result in deterioration. Vasopressors may also be given if IV fluids fail to sufficiently increase blood pressure. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Norepinephrine</span> is the most commonly used first-line agent. Inotropic agents such as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dobutamine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>milrinone</span> should also be considered depending on right ventricular function. </p></div><span id="v54079785" class="anchor"></span><div class="para"> <p>In general,</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v54079788" class="anchor"></span><div class="para"> <p>Patients at low risk should receive anticoagulation alone</p></div></li><li class="topic__listitem"><span id="v54079791" class="anchor"></span><div class="para"> <p>Patients at high risk require anticoagulation plus additional measures such as systemic thrombolysis or surgical or catheter-directed therapy</p></div></li></ul></div><span id="v54079792" class="anchor"></span><div class="para"> <p>For patients at intermediate risk (high or low), treatment considerations are more complicated. Patients who are at intermediate-low risk are most commonly treated with anticoagulation alone. However, patients in intermediate-risk categories require repeat assessment of the entire clinical picture for any clinical deterioration, including</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v54079795" class="anchor"></span><div class="para"> <p>Deterioration of vital signs</p></div></li><li class="topic__listitem"><span id="v54079798" class="anchor"></span><div class="para"> <p>Severity of RV dysfunction by echocardiography</p></div></li><li class="topic__listitem"><span id="v54079802" class="anchor"></span><div class="para"> <p>Amount of oxygen and need for vasopressor agents</p></div></li><li class="topic__listitem"><span id="v54079805" class="anchor"></span><div class="para"> <p>Clot burden and location</p></div></li></ul></div><span id="v14464101" class="anchor"></span><div class="para"> <p><b> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v14464106" data-toggle="tooltip" title="Anticoagulation" data-id="71750234-7c34-442a-8026-50d3562967e3" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">Anticoagulation</a><span id="71750234-7c34-442a-8026-50d3562967e3" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v14464106"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation" loading="lazy"> </span> </a> </span> </span></b> is the mainstay of therapy for PE, and <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v14464375" data-toggle="tooltip" title="Rapid Reduction of Clot Burden" data-id="c4239f92-0495-4e78-8007-6c109d577fae" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">rapid reduction of clot burden</a><span id="c4239f92-0495-4e78-8007-6c109d577fae" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v14464375"> <span class="tooltip-content"> <span class="tooltip-heading"> Rapid Reduction of Clot Burden </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Rapid Reduction of Clot Burden" loading="lazy"> </span> </a> </span> </span> via thrombolytic therapy or embolectomy is indicated for patients with hypotension that does not resolve after fluid resuscitation, and for <i>selected</i> patients with impaired RV function or escalating oxygen requirements. Placement of a removable percutaneous inferior vena cava filter (IVCF) should be considered for patients with contraindications to anticoagulation or for those with recurrent PE despite anticoagulation. For example, patients who have acute PE and residual clot in the leg and cannot be anticoagulated, should have a filter placed because they have persistent risk of subsequent deep venous thrombosis.</p></div><span id="v14464103" class="anchor"></span><div class="para"> <p><b>Hospitalization</b> for at least 24 to 48 hours is done for most patients with PE. Patients with abnormal vital signs or high risk or intermediate risk PE require longer periods of hospitalization. </p></div><span id="v14464104" class="anchor"></span><div class="para"> <p><b>ICU (intensive care unit) admission</b> is required for patients with high risk PE. ICU admission should also be considered if patients have</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v41430458" class="anchor"></span><div class="para"> <p>Extensive clot burden</p></div></li><li class="topic__listitem"><span id="v41430460" class="anchor"></span><div class="para"> <p>RV compromise</p></div></li><li class="topic__listitem"><span id="v41430462" class="anchor"></span><div class="para"> <p>Significant hypoxemia</p></div></li><li class="topic__listitem"><span id="v41430464" class="anchor"></span><div class="para"> <p>Low or borderline blood pressure</p></div></li><li class="topic__listitem"><span id="v41430466" class="anchor"></span><div class="para"> <p>Clinical deterioration</p></div></li></ul></div><span id="v41430467" class="anchor"></span><div class="para"> <p><b>Outpatient management</b> may be used for select patients who are at low risk and have incidentally discovered PE or for those with very small clot burdens and minimal symptoms provided their vital signs are stable, education is undertaken, and a reasonable plan for outpatient treatment and follow-up is in place. </p></div> <section id="v82363806" class="topic__section GHead"> <span></span> <h3 id="Treatment_v915661_v82363807" class="topic__header--subsection"> <span id="v82363807" class="anchor"></span> Pulmonary embolism response team (PERT) </h3> <div class="topic__content"> <span id="v82363808" class="anchor"></span><div class="para"> <p>Given the evolving therapeutic options and the lack of randomized controlled trials, choosing appropriate treatment for individual patients can be challenging. Many hospitals use a multidisciplinary group of clinicians (pulmonary embolus response team) to rapidly evaluate patients, determine the level of pulmonary embolism risk, and make the complex treatment decisions needed. These teams may be comprised of clinicians in pulmonary/critical care medicine, interventional cardiology, interventional radiology, cardiothoracic surgery, hematology, emergency medicine, and other specialties. Recent single-center studies published have shown lower rates of bleeding, shorter time to therapeutic anticoagulation, decreased 30-day mortality, and decreased use of IVC filters in patients whose care is managed by a PERT. The use of PERT in the management of acute PE is now recommended by the European Society of Cardiology (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363812" data-toggle="tooltip" title="General treatment references" data-id="12e12b51-e038-4231-9341-7d68d592476e" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="12e12b51-e038-4231-9341-7d68d592476e" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363812"> <span class="tooltip-content"> <span class="tooltip-heading"> General treatment references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="General treatment references" loading="lazy"> </span> </a> </span> </span>, <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363812" data-toggle="tooltip" title="General treatment references" data-id="cd8e187a-52d0-496c-a5bb-5b58bee7c891" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">2</a><span id="cd8e187a-52d0-496c-a5bb-5b58bee7c891" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363812"> <span class="tooltip-content"> <span class="tooltip-heading"> General treatment references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="General treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v82363811" class="topic__section GHead"> <span></span> <h3 id="Treatment_v915661_v82363812" class="topic__header--subsection"> <span id="v82363812" class="anchor"></span> General treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82363815" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31495443/">Chaudhury P, Gadre SK, Schneider E, et al</a>. Impact of Multidisciplinary Pulmonary Embolism Response Team Availability on Management and Outcomes. <i>Am J Cardiol</i> 2019;124(9):1465-1469. doi:10.1016/j.amjcard.2019.07.043</p></div></li><li class="topic__listitem"><span id="v82363818" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31473594/">Konstantinides SV, Meyer G, Becattini C, et al</a>. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). <i>Eur Respir J</i> 2019;54(3):1901647. doi:10.1183/13993003.01647-2019</p></div></li></ul></div> </div> </section> </div> </section> <section id="v14464105" class="topic__section FHead"> <h2 id="" class="topic__header--section" data-originaltitle="Anticoagulation"> <span id="v14464106" class="anchor"></span> Anticoagulation in Pulmonary Embolism </h2> <div class="topic__content"> <span id="v14464107" class="anchor"></span><div class="para"> <p>Initial anticoagulation followed by maintenance anticoagulation is indicated for patients with acute pulmonary embolism to prevent further embolization as well as new clot formation. Anticoagulant therapy for acute PE should be started whenever PE is strongly suspected, as long as the risk of bleeding is deemed low. Otherwise, anticoagulation should be started as soon as the diagnosis is made. </p></div><span id="v82363821" class="anchor"></span><div class="para"> <p>The likelihood of benefit versus harm in treating emboli in smaller, subsegmental vessels (particularly asymptomatic and incidentally discovered emboli) is currently unknown, and it is possible that for certain patients harm may outweigh benefit. Still, treatment is recommended for the vast majority of patients. </p></div><span id="v82363822" class="anchor"></span><div class="para"> <p>The primary complication of anticoagulation therapy is bleeding, and patients should be closely observed for bleeding during hospitalization.</p></div> <section id="v14464108" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464109" class="anchor"></span> Initial anticoagulation </h3> <div class="topic__content"> <span id="v14464110" class="anchor"></span><div class="para"> <p><b>Initial anticoagulation</b> choices for acute PE include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464113" class="anchor"></span><div class="para"> <p>Intravenous unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></p></div></li><li class="topic__listitem"><span id="v14464115" class="anchor"></span><div class="para"> <p>Subcutaneous low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></p></div></li><li class="topic__listitem"><span id="v14464119" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitors (oral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span>, or subcutaneous <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span>)</p></div></li><li class="topic__listitem"><span id="v82363824" class="anchor"></span><div class="para"> <p>Direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>argatroban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span>) for patients with <span class="genericDrug" data-showrollover="false">heparin</span>-induced thrombocytopenia </p></div></li></ul></div><span id="v14464122" class="anchor"></span><div class="para"> <p><b>Intravenous unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></b> has a short half-life (useful when the potential for bleeding is deemed higher than usual) and is reversible with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span>. An initial bolus of unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> is given, followed by an infusion of <span class="genericDrug" data-showrollover="false">heparin</span> dosed by protocol to achieve an activated partial thromboplastin time (PTT) 1.5 to 2.5 times that of normal control. Therefore, unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> requires ongoing hospitalization to administer. Further, the pharmacokinetics of unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> are relatively unpredictable, resulting in frequent periods of over-anticoagulation and under-anticoagulation and necessitating frequent dose adjustments. Some clinicians prefer this IV unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> regimen when thrombolytic therapy is given or contemplated or when patients are at risk of bleeding because if bleeding occurs, the short half-life means that anticoagulation is quickly reversed after the infusion is stopped. </p></div><span id="v14464134" class="anchor"></span><div class="para"> <p><b>Subcutaneous low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></b> has several advantages over unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> including </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464137" class="anchor"></span><div class="para"> <p>Superior bioavailability</p></div></li><li class="topic__listitem"><span id="v14464139" class="anchor"></span><div class="para"> <p>Weight-based dosing results in a more predictable anticoagulation effect than does weight-based dosing of unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, which allows for quicker time to therapeutic coverage</p></div></li><li class="topic__listitem"><span id="v14464141" class="anchor"></span><div class="para"> <p>Ease of administration (can be given subcutaneously once or twice a day)</p></div></li><li class="topic__listitem"><span id="v14464143" class="anchor"></span><div class="para"> <p>Decreased incidence of bleeding</p></div></li><li class="topic__listitem"><span id="v14464145" class="anchor"></span><div class="para"> <p>Potentially better outcomes</p></div></li><li class="topic__listitem"><span id="v14464147" class="anchor"></span><div class="para"> <p>The potential for patients to self-inject (thereby allowing earlier discharge from the hospital)</p></div></li><li class="topic__listitem"><span id="v14464149" class="anchor"></span><div class="para"> <p>Lower risk of <span class="genericDrug" data-showrollover="false">heparin</span>-induced thrombocytopenia compared with standard, unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></p></div></li></ul></div><span id="v14464150" class="anchor"></span><div class="para"> <p>Low molecular weight heparins that can be used include <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dalteparin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enoxaparin</span>, and tinzaparin.</p></div><span id="v82363826" class="anchor"></span><div class="para"> <p>In patients with renal insufficiency, dose reductions are needed, and subsequent verification of appropriate dosing should be done by checking serum <span class="genericDrug" data-showrollover="false">factor Xa</span> levels (target: 0.5 to 1.2 IU/mL measured at 3 to 4 hours after the 4th dose). Low molecular weight heparins are generally contraindicated in patients with severe renal insufficiency (creatinine clearance < 30 mL/minute). Low molecular weight heparins are partially reversible with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span>.</p></div><span id="v14464218" class="anchor"></span><div class="para"> <p>Adverse effects of all heparins include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464222" class="anchor"></span><div class="para"> <p>Bleeding</p></div></li><li class="topic__listitem"><span id="v14464224" class="anchor"></span><div class="para"> <p>Thrombocytopenia (including <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="06213b05-c0da-4751-b24c-21ffddf21fb5" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="06213b05-c0da-4751-b24c-21ffddf21fb5" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> with the potential for thromboembolism)</p></div></li><li class="topic__listitem"><span id="v14464226" class="anchor"></span><div class="para"> <p>Urticaria</p></div></li><li class="topic__listitem"><span id="v14464228" class="anchor"></span><div class="para"> <p>Anaphylaxis (rare)</p></div></li></ul></div><span id="v14464229" class="anchor"></span><div class="para"> <p>Bleeding caused by over-heparinization with unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> can be treated with a <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> infusion. Over-heparinization with a low molecular weight <span class="genericDrug" data-showrollover="false">heparin</span> can also be treated with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span>.</p></div><span id="v14464230" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fondaparinux</span></b> is a <span class="genericDrug" data-showrollover="false">factor Xa</span> antagonist given subcutaneously. It can be used in acute DVT and acute PE instead of <span class="genericDrug" data-showrollover="false">heparin</span> or low molecular weight <span class="genericDrug" data-showrollover="false">heparin</span>. Outcomes appear to be similar to those of unfractionated <span class="genericDrug" data-showrollover="false">heparin</span>. Advantages include once or twice a day fixed-dose administration, no need for monitoring of the degree of anticoagulation, and lower risk of thrombocytopenia. The drug is contraindicated if creatinine clearance is < 30 mL/minute. </p></div><span id="v14464231" class="anchor"></span><div class="para"> <p>The other <b><span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors,</b> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>, have the advantages of oral fixed dosing and the ability to be used as <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v14464237" data-toggle="tooltip" title="Maintenance anticoagulation" data-id="e3eb1360-e429-44c8-81d3-cf082fe7c059" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">maintenance anticoagulants</a><span id="e3eb1360-e429-44c8-81d3-cf082fe7c059" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v14464237"> <span class="tooltip-content"> <span class="tooltip-heading"> Maintenance anticoagulation </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Maintenance anticoagulation" loading="lazy"> </span> </a> </span> </span> with no need for laboratory monitoring of the anticoagulant effect. They also cause few adverse interactions with other drugs, although azole antifungal therapy and older HIV therapies (protease inhibitors) will increase oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor levels, and certain antiseizure medications and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rifampin</span> will decrease oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor levels. Although <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span> do not require overlap with a parenteral anticoagulant when used as initial therapy, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span> requires use of a parenteral anticoagulant for 5 to 10 days. </p></div><span id="v14464233" class="anchor"></span><div class="para"> <p>Dose reductions are indicated for patients with renal insufficiency. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span> can be used in patients with renal insufficiency, and use is safe in patients undergoing hemodialysis. </p></div><span id="v41430477" class="anchor"></span><div class="para"> <p>Anticoagulation reversal of the oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>) is possible with andexanet, although this drug is not widely used. Reversal of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span> may be possible using recombinant activated factor VII (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="e51b662b-6a89-4183-9737-796a5677578c" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="e51b662b-6a89-4183-9737-796a5677578c" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>). The half-lives of the <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors are much shorter than the half-life for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>. If bleeding develops that requires reversal, use of 4-factor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prothrombin complex concentrate</span> can be considered, and hematology consultation is recommended. </p></div><span id="v41430478" class="anchor"></span><div class="para"> <p>The safety and efficacy of these medications in patients with PE complicated by severe cardiopulmonary decompensation have not yet been studied, and parenteral drugs should be used for anticoagulation in these patients until there is significant improvement in cardiopulmonary function. </p></div><span id="v14464234" class="anchor"></span><div class="para"> <p>The <b>direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitor</b> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span> is also effective for treatment of acute DVT and PE. <span class="genericDrug" data-showrollover="false">Dabigatran</span> requires overlap with a parenteral anticoagulant when used as initial therapy, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Idarucizumab</span> is effective at reversing <span class="genericDrug" data-showrollover="false">dabigatran</span>.</p></div><span id="v14464235" class="anchor"></span><div class="para"> <p>Finally, in patients with suspected or proven <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="f426769e-e638-4fe8-96c5-f27a264350e7" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="f426769e-e638-4fe8-96c5-f27a264350e7" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, intravenous <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>argatroban</span> or subcutaneous <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span> can be used for anticoagulation. Use of the direct oral anticoagulants in this situation has been found to be safe in a recent meta-analysis (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="ec80fb5e-1f08-4c17-91bc-83902b1fe5f3" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">2</a><span id="ec80fb5e-1f08-4c17-91bc-83902b1fe5f3" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v14464236" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464237" class="anchor"></span> Maintenance anticoagulation </h3> <div class="topic__content"> <span id="v14464238" class="anchor"></span><div class="para"> <p><b>Maintenance anticoagulation</b> is indicated to reduce the risk of clot extension or embolization and to reduce the risk of new clot formation. Medication choices for maintenance anticoagulation include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464241" class="anchor"></span><div class="para"> <p>Oral <span class="genericDrug" data-showrollover="false">vitamin K</span> antagonist (VKA) (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span> in the United States)</p></div></li><li class="topic__listitem"><span id="v14464243" class="anchor"></span><div class="para"> <p>Oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>)</p></div></li><li class="topic__listitem"><span id="v14464245" class="anchor"></span><div class="para"> <p>Oral direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitor (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span>)</p></div></li><li class="topic__listitem"><span id="v14464247" class="anchor"></span><div class="para"> <p>Rarely subcutaneous low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> or subcutaneous <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span></p></div></li></ul></div><span id="v14464248" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Warfarin</span></b> is an effective long-term oral anticoagulant option that has been used for decades, but it is inconvenient for a number of reasons. In most patients, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span> is started on the same day as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span>) therapy used for initial anticoagulation. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Heparin</span> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span>) therapy should be overlapped with <span class="genericDrug" data-showrollover="false">warfarin</span> therapy for a minimum of 5 days <i>and</i> until the international normalized ratio (INR) has been within the therapeutic range (2.0 to 3.0) for at least 24 hours. </p></div><span id="v14464250" class="anchor"></span><div class="para"> <p>The major disadvantages of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span> are the need for periodic INR monitoring, with frequent dose adjustments, and drug, supplement, and food interactions. Physicians prescribing <span class="genericDrug" data-showrollover="false">warfarin</span> should be wary of such interactions; in a patient taking <span class="genericDrug" data-showrollover="false">warfarin</span>, virtually any newly ingested drug or substance should be checked. </p></div><span id="v14464251" class="anchor"></span><div class="para"> <p>Bleeding is the most common complication of <span class="genericDrug" data-showrollover="false">warfarin</span> treatment; patients <span class='symbol'>></span> 65 years and those with comorbidities (especially diabetes, recent myocardial infarction, hematocrit <span class='symbol'>&lt</span> 30%, or creatinine <span class='symbol'>></span> 1.5 mg/dL [<span class='symbol'>></span>133 micromol/L]) and a history of stroke or gastrointestinal bleeding seem to be at greatest risk. Bleeding can be reversed with vitamin K and, in an emergency, with fresh frozen plasma or a new concentrate formulation (prothrombin complex concentrates) containing factor II (prothrombin), factor VII, <span class="genericDrug" data-showrollover="false">factor IX</span>, <span class="genericDrug" data-showrollover="false">factor X</span>, protein C, and protein S. Vitamin K may cause flushing, local pain, and, rarely, anaphylaxis. </p></div><span id="v14464253" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Warfarin</span>-induced necrosis, a devastating complication of <span class="genericDrug" data-showrollover="false">warfarin</span> therapy, is a paradoxical hypercoagulable state that can arise upon the initiation of <span class="genericDrug" data-showrollover="false">warfarin</span>. <span class="genericDrug" data-showrollover="false">Warfarin</span> inactivates vitamin K-dependent clotting factors II, VII, IX, and X. At the same time, vitamin K-dependent proteins C and S are inactivated. This may cause a paradoxical hypercoagulable state in which microthrombi form in cutaneous and subcutaneous venules, resulting in skin necrosis. Based on these considerations and the development of more convenient oral anticoagulants, <span class="genericDrug" data-showrollover="false">warfarin</span> use has been declining substantially. However, cost considerations continue to make <span class="genericDrug" data-showrollover="false">warfarin</span>a reasonable treatment option for some patients. </p></div> <a id="v14464254"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--pearlsandpitfalls "> <div class="inlinebox__wrapper" id="v14464256"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464256"></span> <div class="SidebarHalfPage" id="v56251847"> <h3 class="title">Pearls & Pitfalls</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56251856" class="anchor"></span><div class="para"> <p>In a patient taking <span class="genericDrug" data-showrollover="false">warfarin</span>, virtually any new drug or supplement should be checked for potential interactions.</p></div></li></ul></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: PearlsAndPitfalls --> </div><span id="v14464265" class="anchor"></span><div class="para"> <p>The <b>oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor anticoagulants</b> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> can be used for both initial and maintenance anticoagulation therapy (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"b71ae740-c406-45d3-b8e5-e105cd9df3ff","Title":"Oral%20Anticoagulants","ShareUrlTitle":"oral-anticoagulants","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610275","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EOral%20Anticoagulants%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). These drugs are more convenient than <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span> due to their fixed dosing and lack of need for laboratory monitoring, as well as having fewer interactions. In clinical trials, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="e22d4ec9-db07-4367-82b3-23814f94431e" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">3</a><span id="e22d4ec9-db07-4367-82b3-23814f94431e" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>, <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="696148c6-cdf4-40d6-b795-bd31fdc3ee2e" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">4</a><span id="696148c6-cdf4-40d6-b795-bd31fdc3ee2e" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span> (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="3d7ba014-51d6-4401-b365-d99b016e42c3" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">5</a><span id="3d7ba014-51d6-4401-b365-d99b016e42c3" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>), and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span> (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="eb075a55-7afc-4bf8-8e43-933136bb4415" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">6</a><span id="eb075a55-7afc-4bf8-8e43-933136bb4415" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>) were as effective (in non-inferiority analyses) as <span class="genericDrug" data-showrollover="false">warfarin</span> in preventing recurrent DVT and PE. A meta-analysis of large phase III randomized controlled trials found that rates of major bleeding, including intracranial hemorrhage, were significantly lower with oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor anticoagulants than with <span class="genericDrug" data-showrollover="false">warfarin</span> (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="e29823d9-91fb-4f2a-926e-a811ebba2aba" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">7</a><span id="e29823d9-91fb-4f2a-926e-a811ebba2aba" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>). Another advantage of both <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span> is that dosages may be lowered after patients have been treated for 6 to 12 months (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="ea43a0bf-c189-4743-b87f-88e5d1f015e9" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">8</a><span id="ea43a0bf-c189-4743-b87f-88e5d1f015e9" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v14464267" class="anchor"></span><div class="para"> <p>One important caveat is that <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span> requires that a preceding 5 to 10 days of initial <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> or low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> be given. </p></div><span id="v14464268" class="anchor"></span><div class="para"> <p>The direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span> can also be used for maintenance anticoagulation therapy. As with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>, 5 to 10 days of treatment with unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> or low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed before <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span> can be initiated. Clinically relevant bleeding is lower with <span class="genericDrug" data-showrollover="false">dabigatran</span> than with <span class="genericDrug" data-showrollover="false">warfarin</span>. The use of <span class="genericDrug" data-showrollover="false">dabigatran</span> as maintenance therapy has the same advantages and disadvantages as the use of the <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors.</p></div><span id="v41430487" class="anchor"></span><div class="para"> <p>The need for initial <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> treatment before <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span> is given is a reflection of the way the clinical trials were conducted. </p></div> <span id="v14464270"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v14464272"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"b71ae740-c406-45d3-b8e5-e105cd9df3ff","Title":"Oral%20Anticoagulants","ShareUrlTitle":"oral-anticoagulants","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610275","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Oral%20Anticoagulants","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="b71ae740-c406-45d3-b8e5-e105cd9df3ff"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'b71ae740-c406-45d3-b8e5-e105cd9df3ff' }, async: true, success: function (data) { $('#b71ae740-c406-45d3-b8e5-e105cd9df3ff').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v41430492" class="anchor"></span><div class="para"> <p><b>Subcutaneous low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></b> has been used primarily for patients with cancer at high risk of pulmonary embolism or patients with recurrent pulmonary embolism despite the use of other anticoagulants. However, multiple recent trials of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> have been completed in patients with cancer and these agents are now recommended over low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="95bb8e1e-46eb-47f4-b252-5f308c873c3e" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">9</a><span id="95bb8e1e-46eb-47f4-b252-5f308c873c3e" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v14464337" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aspirin</span></b> has been studied for long-term maintenance therapy. It appears more effective than placebo but less effective than all other available anticoagulants. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span>, 10 mg once/day, has proven more effective at reducing recurrent DVT/PE yet is as safe as <span class="genericDrug" data-showrollover="false">aspirin</span> in patients already treated with anticoagulation for 6 to 12 months (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497" data-toggle="tooltip" title="Anticoagulation references" data-id="f6cdc0a3-f9d9-4deb-a6f9-01582a7619be" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">8</a><span id="f6cdc0a3-f9d9-4deb-a6f9-01582a7619be" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v41430497"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulation references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulation references" loading="lazy"> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v14464338" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464339" class="anchor"></span> Duration of anticoagulation </h3> <div class="topic__content"> <span id="v14464340" class="anchor"></span><div class="para"> <p><b>Duration of maintenance anticoagulation</b> for PE is dependent on a variety of factors (eg, risk factors for PE, bleeding risk) and can range from 3 months to lifelong therapy. Clearly transient risk factors (eg, immobilization, recent surgery, trauma) require only 3 months of treatment. Patients with unprovoked PE, those with more durable risk factors for PE (eg, cancer, thrombophilic disorder), and those with recurrent PE might benefit from lifelong anticoagulation provided the bleeding risk is low or moderate. In patients with unprovoked venous thromboembolism, annual assessment of bleeding risk versus clotting risk should be done and an informed joint decision regarding continuing anticoagulation reached. </p></div><span id="v14464341" class="anchor"></span><div class="para"> <p><b>Risk factors for bleeding</b> include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464344" class="anchor"></span><div class="para"> <p>Age > 65 years</p></div></li><li class="topic__listitem"><span id="v14464346" class="anchor"></span><div class="para"> <p>Previous bleeding</p></div></li><li class="topic__listitem"><span id="v14464348" class="anchor"></span><div class="para"> <p>Thrombocytopenia</p></div></li><li class="topic__listitem"><span id="v14464350" class="anchor"></span><div class="para"> <p>Antiplatelet therapy</p></div></li><li class="topic__listitem"><span id="v14464352" class="anchor"></span><div class="para"> <p>Poor anticoagulant control</p></div></li><li class="topic__listitem"><span id="v14464354" class="anchor"></span><div class="para"> <p>Frequent falls</p></div></li><li class="topic__listitem"><span id="v14464356" class="anchor"></span><div class="para"> <p>Liver failure</p></div></li><li class="topic__listitem"><span id="v14464358" class="anchor"></span><div class="para"> <p>Alcohol overuse</p></div></li><li class="topic__listitem"><span id="v14464360" class="anchor"></span><div class="para"> <p>Recent surgery</p></div></li><li class="topic__listitem"><span id="v14464362" class="anchor"></span><div class="para"> <p>Reduced functional capacity</p></div></li><li class="topic__listitem"><span id="v14464364" class="anchor"></span><div class="para"> <p>Previous stroke</p></div></li><li class="topic__listitem"><span id="v14464366" class="anchor"></span><div class="para"> <p>Diabetes</p></div></li><li class="topic__listitem"><span id="v14464368" class="anchor"></span><div class="para"> <p>Anemia</p></div></li><li class="topic__listitem"><span id="v14464370" class="anchor"></span><div class="para"> <p>Cancer</p></div></li><li class="topic__listitem"><span id="v14464372" class="anchor"></span><div class="para"> <p>Renal failure</p></div></li></ul></div><span id="v14464373" class="anchor"></span><div class="para"> <p>Low risk for bleeding is defined as no risk factors for bleeding, moderate risk for bleeding is defined as one risk factor, and high risk for bleeding is defined as two or more risk factors.</p></div><span id="v41430495" class="anchor"></span><div class="para"> <p>As described above, for patients in whom long-term anticoagulation is considered appropriate, after 6 months of treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, dosage decreases can be considered.</p></div> </div> </section> <section id="v41430496" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v41430497" class="anchor"></span> Anticoagulation references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82363867" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31539334/">Yee J, Kaide CG</a>. Emergency Reversal of Anticoagulation. <i>West J Emerg Med</i> 2019;20(5):770-783. doi:10.5811/westjem.2018.5.38235</p></div></li><li class="topic__listitem"><span id="v82363870" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/33857342/">Nilius H, Kaufmann J, Cuker A, Nagler M</a>. Comparative effectiveness and safety of anticoagulants for the treatment of <span class="genericDrug" data-showrollover="false">heparin</span>-induced thrombocytopenia. <i>Am J Hematol</i> 2021;96(7):805-815. doi:10.1002/ajh.26194</p></div></li><li class="topic__listitem"><span id="v41430500" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed?term=21128814">EINSTEIN Investigators, Bauersachs R, Berkowitz SD, et al</a>: Oral <span class="genericDrug" data-showrollover="false">rivaroxaban</span> for symptomatic venous thromboembolism. <i>N Engl J Med </i>363(26):2499–2510, 2010.</p></div></li><li class="topic__listitem"><span id="v41430504" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/22449293">EINSTEIN-PE Investigators, Buller HR, Prins MH, et al</a>: Oral <span class="genericDrug" data-showrollover="false">rivaroxaban</span> for the treatment of symptomatic pulmonary embolism. <i>N Engl J Med</i> 366 (14):1287–1297, 2012.</p></div></li><li class="topic__listitem"><span id="v41430508" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed?term=23808982">Agnelli G, Buller HR, Cohen A, et al</a>: Oral <span class="genericDrug" data-showrollover="false">apixaban</span> for the treatment of acute venous thromboembolism. <i>N Engl J Med</i> 369(9):799–808, 2013.</p></div></li><li class="topic__listitem"><span id="v41430512" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=23991658">Hokusai-VTE Investigators, Buller HR, Decousus H, et al</a>: <span class="genericDrug" data-showrollover="false">Edoxaban</span> versus <span class="genericDrug" data-showrollover="false">warfarin</span> for the treatment of symptomatic venous thromboembolism. <i>N Engl J Med</i> 369(15): 1406–1415, 2013.</p></div></li><li class="topic__listitem"><span id="v41430516" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/24963045">van Es N, Coppens M, Schulman S, et al:</a> Direct oral anticoagulants compared with vitamin K antagonists for acute symptomatic venous thromboembolism: evidence from phase 3 trials. <i>Blood</i>124 (12): 1968–1975, 2014. </p></div></li><li class="topic__listitem"><span id="v41430524" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/28316279">Weitz JI, Lensing AWA, Prins MH, et al</a>: <span class="genericDrug" data-showrollover="false">Rivaroxaban</span> or <span class="genericDrug" data-showrollover="false">aspirin</span> for extended treatment of venous thromboembolism. <i>N Engl J Med</i> 376:1211–1222, 2017. doi: 10.1056/NEJMoa1700518. </p></div></li><li class="topic__listitem"><span id="v82363881" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34352278/">Stevens SM, Woller SC, Kreuziger LB, et al</a>: Antithrombotic therapy for VTE disease: Second update of the CHEST Guideline and Expert Panel Report [published correction appears in <i>Chest</i> 2022 Jul;162(1):269]. <i>Chest</i> 2021;160(6):e545-e608. doi:10.1016/j.chest.2021.07.055</p></div></li></ul></div> </div> </section> </div> </section> <section id="v14464374" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v14464375" class="anchor"></span> Rapid Reduction of Clot Burden </h2> <div class="topic__content"> <span id="v14464376" class="anchor"></span><div class="para"> <p>Clot elimination by means of embolectomy or dissolution with IV or catheter-based thrombolytic therapy should be considered for acute pulmonary embolism associated with hypotension that does not resolve after fluid resuscitation (high-risk/massive PE). Patients who are hypotensive and require vasopressor therapy are obvious candidates. Patients with a systolic blood pressure < 90 mm Hg or a decrease from baseline value in systolic blood pressure > 40 mm Hg that lasts at least 15 minutes despite fluid challenge are hemodynamically compromised and are also candidates. </p></div><span id="v14464377" class="anchor"></span><div class="para"> <p>Although only anticoagulation is generally recommended for patients with mild RV dysfunction (based on clinical, ECG, or echocardiographic findings), thrombolytic therapy or embolectomy may be needed when RV compromise and/or hypoxemia is severe even when hypotension is not present, particularly when deterioration is likely as suggested by an increase in heart rate or decrease in oxygen saturation or blood pressure. </p></div> <section id="v14464378" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464379" class="anchor"></span> Systemic thrombolytic therapy </h3> <div class="topic__content"> <span id="v14464385" class="anchor"></span><div class="para"> <p>Systemic thrombolytic therapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alteplase</span> (tissue <span class="genericDrug" data-showrollover="false">plasminogen</span> activator [tPA]) offers a noninvasive way to rapidly restore pulmonary blood flow, but long-term benefits do not clearly outweigh the risk of hemorrhage in some patients. Experts agree that systemic thrombolytic therapy should be given to patients with hemodynamic compromise if there are no contraindications, particularly when other means of rapidly reducing clot burden are not readily available. Although no prospective randomized trial of systemic thrombolytic therapy has shown improved survival in patients with intermediate-risk/submassive PE, some experts recommend thrombolytics, particularly when patients also have numerous or large clots; very severe RV dysfunction; marked tachycardia; significant hypoxemia; other concomitant findings such as residual clot in the leg, positive troponin values, and/or elevated BNP values; and there are no active contraindications to its administration. Others reserve thrombolytic therapy only for patients with high-risk (massive) PE. </p></div><span id="v14464386" class="anchor"></span><div class="para"> <p><b>Absolute contraindications</b> to thrombolytics include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464389" class="anchor"></span><div class="para"> <p>Prior hemorrhagic stroke</p></div></li><li class="topic__listitem"><span id="v14464391" class="anchor"></span><div class="para"> <p>Ischemic stroke within 1 year</p></div></li><li class="topic__listitem"><span id="v14464393" class="anchor"></span><div class="para"> <p>Active external or internal bleeding from any source</p></div></li><li class="topic__listitem"><span id="v14464395" class="anchor"></span><div class="para"> <p>Intracranial injury or surgery within 2 months</p></div></li><li class="topic__listitem"><span id="v14464397" class="anchor"></span><div class="para"> <p>Intracranial tumor</p></div></li><li class="topic__listitem"><span id="v41430530" class="anchor"></span><div class="para"> <p>Certain surgeries within the previous weeks</p></div></li></ul></div><span id="v14464398" class="anchor"></span><div class="para"> <p><b>Relative contraindications</b> include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v82363884" class="anchor"></span><div class="para"> <p>Age > 75 years</p></div></li><li class="topic__listitem"><span id="v14464401" class="anchor"></span><div class="para"> <p>Recent surgery (≤ 10 days)</p></div></li><li class="topic__listitem"><span id="v14464403" class="anchor"></span><div class="para"> <p>Hemorrhagic diathesis (as in hepatic insufficiency)</p></div></li><li class="topic__listitem"><span id="v14464405" class="anchor"></span><div class="para"> <p>Pregnancy</p></div></li><li class="topic__listitem"><span id="v14464407" class="anchor"></span><div class="para"> <p>Recent punctures of large noncompressible veins (eg, subclavian vein)</p></div></li><li class="topic__listitem"><span id="v14464409" class="anchor"></span><div class="para"> <p>Recent femoral artery catheterization (eg, ≤ 10 days)</p></div></li><li class="topic__listitem"><span id="v14464411" class="anchor"></span><div class="para"> <p>Peptic ulcer disease or other conditions that increase the risk of bleeding</p></div></li><li class="topic__listitem"><span id="v14464413" class="anchor"></span><div class="para"> <p>Severe hypertension (systolic blood pressure > 180 mm Hg or diastolic blood pressure > 110 mm Hg) </p></div></li><li class="topic__listitem"><span id="v41430532" class="anchor"></span><div class="para"> <p>Head trauma from PE-induced syncope, even if brain CT is normal</p></div></li></ul></div><span id="v14464414" class="anchor"></span><div class="para"> <p>Except for concurrent intracerebral hemorrhage, thrombolytic therapy is sometimes given to patients with high-risk (massive) PE who have "absolute contraindications" to such therapy if, without intervention, death is otherwise anticipated. In patients with relative contraindications, the decision to give systemic thrombolytics depends on individual patient factors. </p></div><span id="v14464415" class="anchor"></span><div class="para"> <p>In the United States, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alteplase</span> (tPA) is used for systemic thrombolysis. Streptokinase and urokinase are no longer used for acute PE. </p></div><span id="v14464417" class="anchor"></span><div class="para"> <p>In the United States, when systemic thrombolytics are given, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is usually stopped after the initial loading dose. However, in Europe, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is often continued, and there is no clear determination as to which method is preferred. The bleeding risk should be considered. </p></div><span id="v82363885" class="anchor"></span><div class="para"> <p>Bleeding, if it occurs, can be reversed with cryoprecipitate or fresh frozen plasma. Accessible vascular access sites that are bleeding can be compressed. The potential for bleeding after systemic thrombolysis has led to increased implementation of catheter-directed thrombolysis, because much lower doses of thrombolytic agents are used.</p></div> </div> </section> <section id="v14464453" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464454" class="anchor"></span> Catheter-directed therapy </h3> <div class="topic__content"> <span id="v14464455" class="anchor"></span><div class="para"> <p>Catheter-directed PE therapy (thrombolytics, embolectomy) uses catheter placement in the pulmonary arteries for disruption, removal, and/or lysis of clot. Indications for its use are evolving in patients who are high risk and those at intermediate high risk. In catheter-directed PE thrombolytic therapy, the pulmonary arteries are accessed via a typical pulmonary arteriography procedure, and thrombolytics are delivered directly to large proximal emboli via the catheter. The most widely studied technique uses high-frequency, low-power ultrasonography. Ultrasonography accelerates thrombolysis by disaggregating fibrin strands and increasing permeability of lytic drug into the clot. Studies to date are limited to mainly single-arm studies and registries. One randomized controlled trial, the ULTIMA study, demonstrated that the use of catheter-directed thrombolytics in patients with proximal clot and evidence of RV strain leads to an improved RV/LV ratio at 24 hours compared with anticoagulation alone (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363890" data-toggle="tooltip" title="Rapid reduction in clot burden references" data-id="b1b21d76-f982-4538-85ed-6ab273433ffa" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="b1b21d76-f982-4538-85ed-6ab273433ffa" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363890"> <span class="tooltip-content"> <span class="tooltip-heading"> Rapid reduction in clot burden references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Rapid reduction in clot burden references" loading="lazy"> </span> </a> </span> </span>). However, there was no difference between the groups in RV function, RV/LV ratio at 90 days, or 90-day mortality (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363890" data-toggle="tooltip" title="Rapid reduction in clot burden references" data-id="07f3b63f-6890-48a5-968b-f758a5a977d4" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="07f3b63f-6890-48a5-968b-f758a5a977d4" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363890"> <span class="tooltip-content"> <span class="tooltip-heading"> Rapid reduction in clot burden references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Rapid reduction in clot burden references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v14464457" class="anchor"></span><div class="para"> <p>Mechanical disruption, or removal of the thrombus via suction embolectomy without thrombolysis, is becoming more widely used. Mechanisms of clot removal include direct aspiration or fragmentation with aspiration. Devices for this purpose differ by size of catheter and method of embolectomy. If the use of thrombolysis is contraindicated, catheter-directed suction embolectomy may be considered and, depending on local resources and expertise, tried before surgical embolectomy. Data on the use of suction embolectomy devices are limited to patients at intermediate high risk or high risk who participated in single-arm studies and registries (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363890" data-toggle="tooltip" title="Rapid reduction in clot burden references" data-id="14b02c2e-98c4-4d06-b236-4a137782c0e7" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">2</a><span id="14b02c2e-98c4-4d06-b236-4a137782c0e7" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363890"> <span class="tooltip-content"> <span class="tooltip-heading"> Rapid reduction in clot burden references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Rapid reduction in clot burden references" loading="lazy"> </span> </a> </span> </span>). Randomized controlled trials to help determine appropriate use of these devices in patients with PE are ongoing.</p></div> </div> </section> <section id="v14464458" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464459" class="anchor"></span> Surgical embolectomy </h3> <div class="topic__content"> <span id="v14464460" class="anchor"></span><div class="para"> <p><b>Surgical embolectomy</b> is reserved for patients with PE who are hypotensive despite supportive measures (persistent systolic blood pressure <span class='symbol'>≤</span> 90 mm Hg after fluid therapy and oxygen or if vasopressor therapy is required) or on the verge of cardiac or respiratory arrest. Surgical embolectomy can be considered if use of thrombolysis is contraindicated, although catheter-directed suction embolectomy may be tried first. As with catheter-based thrombosis/clot extraction, the decision to proceed with embolectomy and the choice of technique depend on local resources and expertise. Surgical embolectomy as a management strategy for acute PE is decreasing in frequency as catheter-based percutaneous techniques become more widely available. </p></div> </div> </section> <section id="v41430539" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v41430540" class="anchor"></span> Extracorporeal membrane oxygenation </h3> <div class="topic__content"> <span id="v41430541" class="anchor"></span><div class="para"> <p>Extracorporeal membrane oxygenation (ECMO) has been used increasingly in catastrophic acute pulmonary embolism when thrombolysis is contraindicated or failed. ECMO may serve as a bridge to surgical embolectomy or catheter-directed therapy, or it may buy time for improvement with anticoagulation alone. </p></div> </div> </section> <section id="v82363889" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v82363890" class="anchor"></span> Rapid reduction in clot burden references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82363893" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.113.005544">Kucher N, Boekstegers P, Müller OJ, et al</a>. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. <i>Circulation</i> 2014;129(4):479-486. doi:10.1161/CIRCULATIONAHA.113.005544</p></div></li><li class="topic__listitem"><span id="v82363896" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32740381/">Hountras P, Bull TM</a>. Advanced therapies for pulmonary embolism. <i>Curr Opin Pulm Med</i> 2020;26(5):397-405. doi:10.1097/MCP.0000000000000714</p></div></li></ul></div> </div> </section> </div> </section> <section id="v915657" class="topic__section FHead"> <h2 id="Prognosis_v915658" class="topic__header--section" data-originaltitle="Prognosis"> <span id="v915658" class="anchor"></span> Prognosis for Pulmonary Embolism </h2> <div class="topic__content"> <span id="v915659" class="anchor"></span><div class="para"> <p>Most deaths resulting from pulmonary embolism occur withing 1 hour of presentation (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363902" data-toggle="tooltip" title="Prognosis references" data-id="cdfc075b-4401-4c68-a408-40cf3a4b96e8" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="cdfc075b-4401-4c68-a408-40cf3a4b96e8" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363902"> <span class="tooltip-content"> <span class="tooltip-heading"> Prognosis references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prognosis references" loading="lazy"> </span> </a> </span> </span>). Most patients who die as a result of acute PE are never diagnosed before death. In fact, PE is not suspected in most of these patients. Overall in-hospital mortality rate ranges from approximately 8% in stable patients to 25% in those presenting with cardiogenic shock and to 65% in patients requiring cardiopulmonary resuscitation (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363902" data-toggle="tooltip" title="Prognosis references" data-id="133307d7-cbd2-4abc-a5e9-1d4b6d14f811" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">2</a><span id="133307d7-cbd2-4abc-a5e9-1d4b6d14f811" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363902"> <span class="tooltip-content"> <span class="tooltip-heading"> Prognosis references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prognosis references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v82363900" class="anchor"></span><div class="para"> <p>The best prospects for reducing mortality involve</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464092" class="anchor"></span><div class="para"> <p>Improving the frequency of diagnosis (eg, by including PE in the differential diagnosis when patients present with nonspecific but compatible symptoms or signs)</p></div></li><li class="topic__listitem"><span id="v14464094" class="anchor"></span><div class="para"> <p>Improving the rapidity of diagnosis</p></div></li><li class="topic__listitem"><span id="v54079782" class="anchor"></span><div class="para"> <p>Improving risk stratification </p></div></li><li class="topic__listitem"><span id="v54079784" class="anchor"></span><div class="para"> <p>Improving the rapidity of initiation of anticoagulation therapy</p></div></li><li class="topic__listitem"><span id="v14464096" class="anchor"></span><div class="para"> <p>Providing appropriate prophylaxis in at-risk patients</p></div></li></ul></div><span id="v41430455" class="anchor"></span><div class="para"> <p>Very high D-dimer levels appear to predict a poor outcome.</p></div><span id="v14464097" class="anchor"></span><div class="para"> <p>Patients with chronic thromboembolic disease represent a small, but important fraction of patients with PE who survive. Anticoagulant therapy reduces the rate of recurrence of PE to about 5% and even lower in some cases.</p></div> <section id="v82363901" class="topic__section GHead"> <span></span> <h3 id="Prognosis_v915658_v82363902" class="topic__header--subsection"> <span id="v82363902" class="anchor"></span> Prognosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82363905" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/11888976/">Wood KE</a>. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. <i>Chest</i> 2002;121(3):877-905. doi:10.1378/chest.121.3.877</p></div></li><li class="topic__listitem"><span id="v82363908" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/9350909/">Kasper W, Konstantinides S, Geibel A, et al</a>. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. <i>J Am Coll Cardiol</i> 1997;30(5):1165-1171. doi:10.1016/s0735-1097(97)00319-7</p></div></li></ul></div> </div> </section> </div> </section> <section id="v14464461" class="topic__section FHead" itemprop="primaryPrevention" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="" class="topic__header--section" data-originaltitle="Prevention"> <span id="v14464462" class="anchor"></span> Prevention of Pulmonary Embolism </h2> <div class="topic__content"> <section id="v14464463" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="" class="topic__header--subsection"> <span itemprop="name" id="v14464464" class="anchor"></span> Prevention of acute venous thromboembolism </h3> <div class="topic__content"> <span id="v14464467" class="anchor"></span><div class="para"> <p>Prevention of pulmonary embolism means prevention of deep venous thrombosis (DVT); the need depends on the patient’s risks, including</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464470" class="anchor"></span><div class="para"> <p>Type and duration of any surgery</p></div></li><li class="topic__listitem"><span id="v14464472" class="anchor"></span><div class="para"> <p>Comorbid conditions, including cancer and hypercoagulable disorders</p></div></li><li class="topic__listitem"><span id="v14464474" class="anchor"></span><div class="para"> <p>Presence of a central venous catheter</p></div></li><li class="topic__listitem"><span id="v14464476" class="anchor"></span><div class="para"> <p>Prior history of DVT or PE</p></div></li></ul></div><span id="v14464477" class="anchor"></span><div class="para"> <p>Bedbound hospitalized patients and patients undergoing surgical, especially orthopedic, procedures benefit significantly from venous thromboembolism prophylaxis, and most of these patients can be identified before a thrombus forms (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"4fb2e44f-e9d1-4df1-af1b-935f914d961a","Title":"Risk%20Assessment%20for%20Thrombosis","ShareUrlTitle":"risk-assessment-for-thrombosis","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610370","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ERisk%20Assessment%20for%20Thrombosis%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). Preventive measures include low-dose unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span>, direct oral anticoagulants (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>), compression devices, and elastic compression stockings. </p></div><span id="v14464479" class="anchor"></span><div class="para"> <p>Choice of drug or device depends on various factors, including patient demographics, the perceived risk, contraindications (eg, bleeding risk), relative costs, and ease of use. The American College of Chest Physicians has published comprehensive evidence-based recommendations for prophylaxis of acute DVT, including the duration of prophylaxis, in surgical and nonsurgical patients and during pregnancy (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926" data-toggle="tooltip" title="Prevention references" data-id="bd4495fc-a614-4fc8-a78b-bd99ff0a6080" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">1</a><span id="bd4495fc-a614-4fc8-a78b-bd99ff0a6080" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prevention references" loading="lazy"> </span> </a> </span> </span>, <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926" data-toggle="tooltip" title="Prevention references" data-id="09c8083e-c1ce-4ead-91ca-4678d118378b" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">2</a><span id="09c8083e-c1ce-4ead-91ca-4678d118378b" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prevention references" loading="lazy"> </span> </a> </span> </span>). The need for prophylaxis has been studied in numerous patient populations. </p></div><span id="v14464482" class="anchor"></span><div class="para"> <p>The type of surgery as well as patient-specific factors determine the risk of DVT. Independent risk factors include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464485" class="anchor"></span><div class="para"> <p>Age <span class='symbol'>≥</span> 60 years</p></div></li><li class="topic__listitem"><span id="v14464487" class="anchor"></span><div class="para"> <p>Prior DVT or PE</p></div></li><li class="topic__listitem"><span id="v14464489" class="anchor"></span><div class="para"> <p>Cancer</p></div></li><li class="topic__listitem"><span id="v14464491" class="anchor"></span><div class="para"> <p>Anesthesia <span class='symbol'>≥</span> 2 hours</p></div></li><li class="topic__listitem"><span id="v14464493" class="anchor"></span><div class="para"> <p>Bed rest <span class='symbol'>≥</span> 4 days</p></div></li><li class="topic__listitem"><span id="v14464495" class="anchor"></span><div class="para"> <p>Male sex</p></div></li><li class="topic__listitem"><span id="v14464497" class="anchor"></span><div class="para"> <p>Hospital stay ≥ 2 days</p></div></li><li class="topic__listitem"><span id="v14464499" class="anchor"></span><div class="para"> <p>Sepsis</p></div></li><li class="topic__listitem"><span id="v14464501" class="anchor"></span><div class="para"> <p>Pregnancy or the postpartum state</p></div></li><li class="topic__listitem"><span id="v14464503" class="anchor"></span><div class="para"> <p>Central venous access</p></div></li><li class="topic__listitem"><span id="v14464505" class="anchor"></span><div class="para"> <p>Body mass index (BMI) > 40</p></div></li></ul></div><span id="v14464506" class="anchor"></span><div class="para"> <p>The Caprini score is commonly used for DVT risk stratification and determination of the need for DVT prophylaxis in surgical patients (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"4fb2e44f-e9d1-4df1-af1b-935f914d961a","Title":"Risk%20Assessment%20for%20Thrombosis","ShareUrlTitle":"risk-assessment-for-thrombosis","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610370","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ERisk%20Assessment%20for%20Thrombosis%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>).</p></div> <span id="v14464508"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v14464510"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"4fb2e44f-e9d1-4df1-af1b-935f914d961a","Title":"Risk%20Assessment%20for%20Thrombosis","ShareUrlTitle":"risk-assessment-for-thrombosis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610370","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Risk%20Assessment%20for%20Thrombosis","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="4fb2e44f-e9d1-4df1-af1b-935f914d961a"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '4fb2e44f-e9d1-4df1-af1b-935f914d961a' }, async: true, success: function (data) { $('#4fb2e44f-e9d1-4df1-af1b-935f914d961a').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v14464764" class="anchor"></span><div class="para"> <p>The need for DVT prophylaxis is based on the risk assessment score (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"d0caedbe-74d1-41a3-bc57-f735a532f047","Title":"Prophylaxis%20Based%20on%20Caprini%20Score","ShareUrlTitle":"prophylaxis-based-on-caprini-score","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610625","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EProphylaxis%20Based%20on%20Caprini%20Score%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). Appropriate preventive measures, ranging from early ambulation to use of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, depend on the total score.</p></div> <span id="v14464766"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v14464768"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"d0caedbe-74d1-41a3-bc57-f735a532f047","Title":"Prophylaxis%20Based%20on%20Caprini%20Score","ShareUrlTitle":"prophylaxis-based-on-caprini-score","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610625","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Prophylaxis%20Based%20on%20Caprini%20Score","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="d0caedbe-74d1-41a3-bc57-f735a532f047"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'd0caedbe-74d1-41a3-bc57-f735a532f047' }, async: true, success: function (data) { $('#d0caedbe-74d1-41a3-bc57-f735a532f047').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v14464813" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464814" class="anchor"></span> Medication regimens for pulmonary embolism prevention </h3> <div class="topic__content"> <span id="v14464815" class="anchor"></span><div class="para"> <p>Medication therapy to prevent DVT is usually delayed until after surgery to help avoid intraoperative bleeding. However, preoperative prophylaxis is also effective.</p></div><span id="v14464816" class="anchor"></span><div class="para"> <p>In general surgery patients, <b>low dose unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></b> is given for 7 to 10 days or until the patient is fully ambulatory. Immobilized patients not undergoing surgery should also receive low dose unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> until they are ambulatory.</p></div><span id="v14464817" class="anchor"></span><div class="para"> <p><b>Low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span></b> dosing for <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941221" data-toggle="tooltip" title="Prevention" data-id="ad831379-f19f-41a8-afc8-06578c7fb684" data-itemid="40a030fa-c405-40db-867d-6853f28279be">DVT prophylaxis</a><span id="ad831379-f19f-41a8-afc8-06578c7fb684" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941221"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prevention" loading="lazy"> </span> </a> </span> </span> depends on the specific drug (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enoxaparin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dalteparin</span>, tinzaparin). Low molecular weight heparins are at least as effective as low dose unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> for preventing DVT and PE.</p></div><span id="v14464819" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fondaparinux</span></b> 2.5 mg subcutaneously once a day is as effective as low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> for patients who have undergone orthopedic surgery and for patients with <span class="genericDrug" data-showrollover="false">heparin</span>-induced thrombocytopenia or some other situations, such as after major orthopedic surgery (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926" data-toggle="tooltip" title="Prevention references" data-id="32d52035-32bd-47b3-a072-b5601af11623" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">3</a><span id="32d52035-32bd-47b3-a072-b5601af11623" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prevention references" loading="lazy"> </span> </a> </span> </span>). It is a selective <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor.</p></div><span id="v14464821" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Warfarin</span></b> is usually effective and safe at a dose adjusted to maintain an INR of 2 to 3 in patients who have undergone total hip or knee replacement. <span class="genericDrug" data-showrollover="false">Warfarin</span> use is increasingly being supplanted by the use of direct oral anticoagulants.</p></div><span id="v14464827" class="anchor"></span><div class="para"> <p>The <b>direct oral anticoagulants</b> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span> are <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors. They can be used for prevention of acute DVT/PE in patients undergoing total knee or hip arthroplasty. </p></div> </div> </section> <section id="v14464829" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464830" class="anchor"></span> Prophylactic devices for pulmonary embolism </h3> <div class="topic__content"> <span id="v14464831" class="anchor"></span><div class="para"> <p>Inferior vena cava filters, intermittent pneumatic compression (also known as sequential compression devices [SCD]), and graded elastic compression stockings may be used alone or in combination with medications to prevent PE. Whether these devices are used alone or in combination depends on the specific indication.</p></div><span id="v14464832" class="anchor"></span><div class="para"> <p>An <b>inferior vena cava filter</b> (IVCF) may help prevent PE in patients with DVT in the leg or pelvic vasculature, but IVCF placement may risk long-term complications. More recent evidence raises questions regarding the efficacy of retrievable filters in patients receiving anticoagulation (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926" data-toggle="tooltip" title="Prevention references" data-id="1a019f7f-1273-440c-91bc-a2a4f436e329" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">4</a><span id="1a019f7f-1273-440c-91bc-a2a4f436e329" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prevention references" loading="lazy"> </span> </a> </span> </span>). A filter is most clearly indicated in patients who have </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464837" class="anchor"></span><div class="para"> <p>Proven DVT and contraindications to anticoagulation</p></div></li><li class="topic__listitem"><span id="v14464839" class="anchor"></span><div class="para"> <p>Recurrent DVT (or emboli) despite adequate anticoagulation</p></div></li><li class="topic__listitem"><span id="v14464843" class="anchor"></span><div class="para"> <p>Possibly marginal cardiopulmonary function, causing concern for their ability to tolerate additional small emboli</p></div></li></ul></div><span id="v14464844" class="anchor"></span><div class="para"> <p>Because venous collaterals can develop, providing a pathway for emboli to circumvent long-standing IVCFs, and because filters occasionally thrombose, patients with recurrent DVT or nonmodifiable risk factors for DVT may still require anticoagulation. An IVCF is placed in the inferior vena cava just below the renal veins via catheterization of an internal jugular or femoral vein. Most IVCFs used currently are removable. Occasionally, a filter dislodges and may migrate up the venous bed, even to the heart or pulmonary vasculature. A filter can also become thrombosed, causing severe venous congestion (including acute phlegmasia cerulea dolens) in the leg, lower body ischemia, and acute kidney injury (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926" data-toggle="tooltip" title="Prevention references" data-id="e31bc688-8ecb-43f0-87c4-645c789a9bb3" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">5</a><span id="e31bc688-8ecb-43f0-87c4-645c789a9bb3" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prevention references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v14464845" class="anchor"></span><div class="para"> <p><b>Intermittent pneumatic compression</b> (IPC) with SCDs provides rhythmic external compression to the legs or to the legs and thighs. It is more effective for preventing calf than proximal DVT. It is insufficient as sole prophylaxis after hip or knee replacement but is often used in low-risk patients after other types of surgery or in medical patients who have a low-risk of DVT or who are at high risk of bleeding. IPC can theoretically trigger PE in immobilized patients who have developed occult DVT while not receiving DVT prophylaxis.</p></div><span id="v14464847" class="anchor"></span><div class="para"> <p><b>Graded elastic compression stockings</b> are likely less effective than external pneumatic leg compression.</p></div> </div> </section> <section id="v14464851" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v14464852" class="anchor"></span> Choices for prevention of pulmonary embolism </h3> <div class="topic__content"> <span id="v14464853" class="anchor"></span><div class="para"> <p>After surgical procedures with a high incidence of DVT/PE, low dose unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, or adjusted-dose <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span> is recommended. </p></div><span id="v14464854" class="anchor"></span><div class="para"> <p>After <b>orthopedic surgery of the hip or knee,</b> additional options include the direct oral anticoagulants <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>. These medications are safe and effective and, unlike <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>, they do not require laboratory tests to monitor the level of anticoagulation. </p></div><span id="v14464855" class="anchor"></span><div class="para"> <p>For <b>total hip arthroplasty,</b> patients should continue to take anticoagulants for 35 days postoperatively. In selected patients at very high risk of both DVT/PE and bleeding, temporary placement of an IVCF is an option for prophylaxis.</p></div><span id="v14464856" class="anchor"></span><div class="para"> <p><b>In patients undergoing elective neurosurgical procedures,</b> the risk of DVT/PE is also high. Because of concern about intracranial bleeding, physical methods (SCDs and elastic stockings) have often been used in patients undergoing neurosurgery; however, low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> appears to be an acceptable alternative. Although no specific guidelines exist, the combination of SCDs and low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> may be more effective than either alone in patients who are at high risk. </p></div><span id="v82363923" class="anchor"></span><div class="para"> <p>In <b>patients with spinal cord injury or multiple trauma,</b> limited data support the combination of SCDs, elastic compression stockings, and low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> to prevent DVT/PE (<a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926" data-toggle="tooltip" title="Prevention references" data-id="a28e0f22-b35b-470e-8978-7e8251bf0be7" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">6</a><span id="a28e0f22-b35b-470e-8978-7e8251bf0be7" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html#v82363926"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prevention references" loading="lazy"> </span> </a> </span> </span>). For patients at very high risk, a temporary IVCF may be considered.</p></div><span id="v14464860" class="anchor"></span><div class="para"> <p>In <b>acutely ill medical patients,</b> low dose unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span> can be given. SCDs, elastic compression stockings, or both may be used when anticoagulants are contraindicated. For patients with ischemic stroke, low dose unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> or low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> can be used; SCD, elastic compression stockings, or both may be beneficial.</p></div> </div> </section> <section id="v82363925" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="" class="topic__header--subsection"> <span itemprop="name" id="v82363926" class="anchor"></span> Prevention references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82363929" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/26867832/">Kearon C, Akl EA, Ornelas J, et al</a>. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report [published correction appears in <i>Chest</i> 2016 Oct;150(4):988]. <i>Chest</i> 2016;149(2):315-352. doi:10.1016/j.chest.2015.11.026</p></div></li><li class="topic__listitem"><span id="v82363932" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34352278/">Stevens SM, Woller SC, Kreuziger LB, et al</a>. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report [published correction appears in <i>Chest</i> 2022 Jul;162(1):269]. <i>Chest</i> 2021;160(6):e545-e608. doi:10.1016/j.chest.2021.07.055</p></div></li><li class="topic__listitem"><span id="v82363935" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/14565815/">Tran AH, Lee G</a>. <span class="genericDrug" data-showrollover="false">Fondaparinux</span> for prevention of venous thromboembolism in major orthopedic surgery. <i>Ann Pharmacother</i> 2003;37(11):1632-1643. doi:10.1345/aph.1C104</p></div></li><li class="topic__listitem"><span id="v82363939" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/25919526/">Mismetti P, Laporte S, Pellerin O, et al</a>. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. <i>JAMA</i> 2015;313(16):1627-1635. doi:10.1001/jama.2015.3780</p></div></li><li class="topic__listitem"><span id="v82363942" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32795479/">Marron RM, Rali P, Hountras P, Bull TM</a>. Inferior Vena Cava Filters: Past, Present, and Future. <i>Chest</i> 2020;158(6):2579-2589. doi:10.1016/j.chest.2020.08.002</p></div></li><li class="topic__listitem"><span id="v82363945" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/12037712/">Aito S, Pieri A, D'Andrea M, Marcelli F, Cominelli E</a>. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. <i>Spinal Cord</i> 2002;40(6):300-303. doi:10.1038/sj.sc.3101298</p></div></li></ul></div> </div> </section> </div> </section> <section id="v14464867" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v14464868" class="topic__header--section"> <span id="v14464868" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v14464871" class="anchor"></span><div class="para"> <p>Acute pulmonary embolism (PE) is a common and potentially devastating medical condition.</p></div></li><li class="topic__listitem"><span id="v14464873" class="anchor"></span><div class="para"> <p>Clinical suspicion and a confirmatory diagnosis are essential because in most patients who die from acute PE, PE is not even suspected.</p></div></li><li class="topic__listitem"><span id="v14464875" class="anchor"></span><div class="para"> <p>Because anticoagulation improves survival, patients should be given anticoagulants when PE is diagnosed or strongly suspected.</p></div></li><li class="topic__listitem"><span id="v14464877" class="anchor"></span><div class="para"> <p>Patients with high risk/massive PE and certain patients with intermediate risk/submassive PE should be considered for thrombolytic therapy or embolectomy.</p></div></li><li class="topic__listitem"><span id="v14464879" class="anchor"></span><div class="para"> <p>Prevention of deep venous thrombosis (and thus PE) should be considered in all patients who are hospitalized and at risk.</p></div></li></ul></div> </div> </section> <section id="v14464880" class="topic__section FHead"> <h2 id="Further_v14464881" class="topic__header--section"> <span id="v14464881" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v54079859" class="anchor"></span><div class="para"> <p>The following English-language resources may be useful. Please note that THE MANUAL is not responsible for the content of these resources.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v54079861" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31504429/">Konstantinides SV, Meyer G, Becattini C, et al</a>: 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405</p></div></li><li class="topic__listitem"><span id="v82363948" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34352278/">Stevens SM, Woller SC, Kreuziger LB, et al</a>. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report [published correction appears in <i>Chest</i> 2022 Jul;162(1):269]. <i>Chest</i> 2021;160(6):e545-e608. doi:10.1016/j.chest.2021.07.055</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="415.1">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '415.1',
 title: 'Pulmonary Embolism (PE)',
 itemGuid: '04bdb331-74e7-4552-b984-0e863fc6c2cd'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{158ED3D8-7B77-490A-98EE-E29670D7E361}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Pneumocystis jirovecii Pneumonia</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{1B50BA92-02A4-4CF7-A711-2B722138B371}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Nonthrombotic Pulmonary Embolism</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="f422da9b-bf2f-4801-933f-8abe0fdd6312_mobile" usemap="#f422da9b-bf2f-4801-933f-8abe0fdd6312_mobile" width="326" height="90">
 <map name="f422da9b-bf2f-4801-933f-8abe0fdd6312_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="f422da9b-bf2f-4801-933f-8abe0fdd6312_tablet" usemap="#f422da9b-bf2f-4801-933f-8abe0fdd6312_tablet" width="326" height="90">
 <map name="f422da9b-bf2f-4801-933f-8abe0fdd6312_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="f422da9b-bf2f-4801-933f-8abe0fdd6312_desktop" usemap="#f422da9b-bf2f-4801-933f-8abe0fdd6312_desktop" width="326" height="90">
 <map name="f422da9b-bf2f-4801-933f-8abe0fdd6312_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd02
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="04BDB33174E74552B9840E863FC6C2CD">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v55610275'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464272"></span> <div class="TableFullPage" id="v55610275"> <h3 class="title">Oral Anticoagulants</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610284" class="anchor"></span><div class="para"> <p>Drug</p></div></th><th style='text-align:left' scope='col'><span id="v55610288" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610293" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitors</p></div></p></td></tr><tr class="even"><td><span id="v55610296" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span></p></div></td><td><span id="v55610301" class="anchor"></span><div class="para"> <p>Dosage may be lowered after 6–12 months of treatment.</p></div></td></tr><tr class="odd"><td><span id="v55610304" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span></p></div></td><td><span id="v55610309" class="anchor"></span><div class="para"> <p>Initial treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5–10 days.</p></div><span id="v55610310" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span> should not be used if creatinine clearance is < 15 ml/minute><span class='symbol'></span> 0.25 mL/second).</p></div></td></tr><tr class="even"><td><span id="v55610313" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span></p></div></td><td><span id="v55610318" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span> should not be used for DVT or PE if creatinine clearance is < 30 ml/minute>< 0.5 ml/second).></p></div><span id="v55610319" class="anchor"></span><div class="para"> <p>Dosage may be lowered to 10 mg once/day after 6–12 months of treatment.</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610323" class="anchor"></span><div class="para"> <p>Factor IIa (<span class="genericDrug" data-showrollover="false">thrombin</span>) inhibitor</p></div></p></td></tr><tr class="even"><td><span id="v55610326" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span></p></div></td><td><span id="v55610330" class="anchor"></span><div class="para"> <p>Initial treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5–10 days.</p></div><span id="v55610331" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span> should not be used for DVT if creatinine clearance is < 30></p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v55610625'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464768"></span> <div class="TableFullPage" id="v55610625"> <h3 class="title">Prophylaxis Based on Caprini Score</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610634" class="anchor"></span><div class="para"> <p>Points</p></div></th><th style='text-align:left' scope='col'><span id="v55610636" class="anchor"></span><div class="para"> <p>Risk</p></div></th><th style='text-align:left' scope='col'><span id="v55610638" class="anchor"></span><div class="para"> <p>Prophylaxis</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v55610642" class="anchor"></span><div class="para"> <p>0</p></div></td><td><span id="v55610644" class="anchor"></span><div class="para"> <p>Very low</p></div></td><td><span id="v55610646" class="anchor"></span><div class="para"> <p>Early ambulation</p></div></td></tr><tr class="even"><td><span id="v55610649" class="anchor"></span><div class="para"> <p>1–2</p></div></td><td><span id="v55610651" class="anchor"></span><div class="para"> <p>Low</p></div></td><td><span id="v55610653" class="anchor"></span><div class="para"> <p>Sequential compression device (SCD)</p></div></td></tr><tr class="odd"><td><span id="v55610656" class="anchor"></span><div class="para"> <p>3–4</p></div></td><td><span id="v55610658" class="anchor"></span><div class="para"> <p>Moderate</p></div></td><td><span id="v55610660" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Heparin</span> every 8 hours or low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> +/- SCD</p></div></td></tr><tr class="even"><td><span id="v55610663" class="anchor"></span><div class="para"> <p>≥ 5</p></div></td><td><span id="v55610665" class="anchor"></span><div class="para"> <p>High</p></div></td><td><span id="v55610667" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Heparin</span> or low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> + SCD</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v55610370'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464510"></span> <div class="TableFullPage" id="v55610370"> <h3 class="title">Risk Assessment for Thrombosis</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610378" class="anchor"></span><div class="para"> <p>Risk Factor</p></div></th><th style='text-align:left' scope='col'><span id="v55610380" class="anchor"></span><div class="para"> <p>Score</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610403" class="anchor"></span><div class="para"> <p>Age (years)</p></div></p></td></tr><tr class="even"><td><span id="v55610406" class="anchor"></span><div class="para"> <p>41–60</p></div></td><td><span id="v55610408" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610411" class="anchor"></span><div class="para"> <p>60–74</p></div></td><td><span id="v55610413" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610416" class="anchor"></span><div class="para"> <p>≥ 75</p></div></td><td><span id="v55610418" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610422" class="anchor"></span><div class="para"> <p>Surgery</p></div></p></td></tr><tr class="even"><td><span id="v55610425" class="anchor"></span><div class="para"> <p>Minor surgery during current hospitalization</p></div></td><td><span id="v55610427" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610430" class="anchor"></span><div class="para"> <p> Major surgery within the past 1 month </p></div></td><td><span id="v55610432" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610435" class="anchor"></span><div class="para"> <p>Arthroscopic surgery during current hospitalization</p></div></td><td><span id="v55610437" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610440" class="anchor"></span><div class="para"> <p>Major surgery lasting > 45 minutes during current hospitalization</p></div></td><td><span id="v55610442" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610445" class="anchor"></span><div class="para"> <p>Laparoscopic surgery lasting > 45 minutes during current hospitalization</p></div></td><td><span id="v55610447" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610450" class="anchor"></span><div class="para"> <p>Elective major arthroplasty of the leg during current hospitalization</p></div></td><td><span id="v55610452" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610456" class="anchor"></span><div class="para"> <p>Coexisting conditions</p></div></p></td></tr><tr class="odd"><td><span id="v55610459" class="anchor"></span><div class="para"> <p>Varicose veins</p></div></td><td><span id="v55610461" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610464" class="anchor"></span><div class="para"> <p>Inflammatory bowel disease</p></div></td><td><span id="v55610466" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610469" class="anchor"></span><div class="para"> <p>Edema, leg (current)</p></div></td><td><span id="v55610471" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610474" class="anchor"></span><div class="para"> <p>Obesity (BMI > 25)</p></div></td><td><span id="v55610476" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610479" class="anchor"></span><div class="para"> <p>Acute myocardial infarction</p></div></td><td><span id="v55610481" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610484" class="anchor"></span><div class="para"> <p>Heart failure within the preceding 1 month</p></div></td><td><span id="v55610486" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610489" class="anchor"></span><div class="para"> <p>Sepsis within the preceding 1 month</p></div></td><td><span id="v55610491" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610494" class="anchor"></span><div class="para"> <p>Serious lung disease* within the preceding 1 month</p></div></td><td><span id="v55610496" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610499" class="anchor"></span><div class="para"> <p>Abnormal pulmonary function (eg, COPD)</p></div></td><td><span id="v55610501" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610504" class="anchor"></span><div class="para"> <p>Central venous access</p></div></td><td><span id="v55610506" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610509" class="anchor"></span><div class="para"> <p>Cancer (present or previous)</p></div></td><td><span id="v55610511" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610514" class="anchor"></span><div class="para"> <p>History of DVT/PE</p></div></td><td><span id="v55610516" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610519" class="anchor"></span><div class="para"> <p>Family history of thrombosis†</p></div></td><td><span id="v55610521" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610524" class="anchor"></span><div class="para"> <p>Factor V Leiden mutation</p></div></td><td><span id="v55610526" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610529" class="anchor"></span><div class="para"> <p>Prothrombin 20210A mutation</p></div></td><td><span id="v55610531" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610534" class="anchor"></span><div class="para"> <p>Elevated serum homocysteine</p></div></td><td><span id="v55610536" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610539" class="anchor"></span><div class="para"> <p>Positive lupus anticoagulant</p></div></td><td><span id="v55610541" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610544" class="anchor"></span><div class="para"> <p>Elevated anticardiolipin antibodies</p></div></td><td><span id="v55610546" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610549" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Heparin</span>-induced thrombocytopenia</p></div></td><td><span id="v55610551" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610554" class="anchor"></span><div class="para"> <p>Other congenital or acquired thrombophilia</p></div></td><td><span id="v55610556" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610559" class="anchor"></span><div class="para"> <p>Stroke within the preceding 1 month</p></div></td><td><span id="v55610561" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even"><td><span id="v55610564" class="anchor"></span><div class="para"> <p>Multiple trauma within the preceding 1 month </p></div></td><td><span id="v55610566" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="odd"><td><span id="v55610569" class="anchor"></span><div class="para"> <p>Acute spinal cord injury/paralysis within the preceding 1 month</p></div></td><td><span id="v55610571" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610575" class="anchor"></span><div class="para"> <p>Immobilization</p></div></p></td></tr><tr class="odd"><td><span id="v55610578" class="anchor"></span><div class="para"> <p>Current bed rest (medical patient)</p></div></td><td><span id="v55610580" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610583" class="anchor"></span><div class="para"> <p>Bed rest > 72 hours</p></div></td><td><span id="v55610585" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610588" class="anchor"></span><div class="para"> <p>Immobilizing plaster cast within the preceding 1 month</p></div></td><td><span id="v55610590" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610593" class="anchor"></span><div class="para"> <p>Hip, pelvis, or leg fracture within the preceding 1 month</p></div></td><td><span id="v55610595" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610599" class="anchor"></span><div class="para"> <p>Additional risk factors for women</p></div></p></td></tr><tr class="even"><td><span id="v55610602" class="anchor"></span><div class="para"> <p>Oral contraceptive use or hormone replacement therapy</p></div></td><td><span id="v55610604" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610607" class="anchor"></span><div class="para"> <p>Pregnancy or postpartum within the preceding 1 month</p></div></td><td><span id="v55610609" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610612" class="anchor"></span><div class="para"> <p>History of unexplained stillbirth, recurrent spontaneous abortion (≥ 3), premature birth with toxemia or growth-restricted infant</p></div></td><td><span id="v55610614" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610618" class="anchor"></span><div class="para"> <p>Other</p></div></p></td></tr><tr class="even"><td><span id="v55610621" class="anchor"></span><div class="para"> <p>Other risk factors‡</p></div></td><td><span id="v55610623" class="anchor"></span><div class="para"> <p>1</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v55610384" class="anchor"></span><div class="para"> <p>* Serious lung disease includes pneumonia.</p></div></td></tr><tr><td colspan="2"><span id="v55610387" class="anchor"></span><div class="para"> <p>† Family history of thrombosis is the most frequently missed risk factor.</p></div></td></tr><tr><td colspan="2"><span id="v55610390" class="anchor"></span><div class="para"> <p>‡ Other risk factors include BMI > 40, smoking, diabetes requiring <span class="genericDrug" data-showrollover="false">insulin</span> therapy, chemotherapy, blood transfusions, and length of surgery > 2 hours.</p></div></td></tr><tr><td colspan="2"><span id="v55610394" class="anchor"></span><div class="para"> <p>Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/22315263/">Gould MK, Garcia DA, Wren SM, et al</a>. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published correction appears in <i>Chest</i> 2012 May;141(5):1369]. <i>Chest</i> 2012;141(2 Suppl):e227S-e277S. doi:10.1378/chest.11-2297</p></div></td></tr><tr><td colspan="2"><span id="v55610398" class="anchor"></span><div class="para"> <p>BMI = body mass index; COPD = chronic obstructive pulmonary disease; DVT = deep vein thrombosis; PE = pulmonary embolism.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v55610056'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v915358"></span> <div class="TableHalfPage" id="v55610056"> <h3 class="title">Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><span id="v55610063" class="anchor"></span><div class="para"> <p>Age > 60 years</p></div></td></tr><tr class="even"><td><span id="v55610066" class="anchor"></span><div class="para"> <p>Cancer and <a href="./{03CAB393-E97F-43C1-ACFF-2A01DB295336}.html" data-toggle="tooltip" title="Overview of Myeloproliferative Neoplasms" data-id="295a3b2f-bc5b-4f4b-a3e2-4c29b08f9348" data-itemid="03cab393-e97f-43c1-acff-2a01db295336">myeloproliferative neoplasms</a><span id="295a3b2f-bc5b-4f4b-a3e2-4c29b08f9348" class="d-none xref"> <span class="tooltip-container"> <a href="./{03CAB393-E97F-43C1-ACFF-2A01DB295336}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Myeloproliferative Neoplasms </span> Myeloproliferative neoplasms are clonal proliferations of bone marrow hematopoietic stem cells, which can manifest as an increased number of functionally normal platelets, red blood cells (RBCs)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div><span id="v55610068" class="anchor"></span><div class="para"> <p>Certain chemotherapeutic agents (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>thalidomide</span>)</p></div></td></tr><tr class="odd"><td><span id="v55610071" class="anchor"></span><div class="para"> <p>Hormonal modulation </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v55610074" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Estrogen</span> receptor modulators (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span>)</p></div></li><li class="topic__listitem"><span id="v55610077" class="anchor"></span><div class="para"> <p>Exogenous <span class="genericDrug" data-showrollover="false">estrogens</span> and progestins, including oral contraceptives and <span class="genericDrug" data-showrollover="false">estrogen</span> therapy </p></div></li><li class="topic__listitem"><span id="v55610081" class="anchor"></span><div class="para"> <p>Exogenous <span class="genericDrug" data-showrollover="false">testosterone</span></p></div></li></ul></div></td></tr><tr class="even"><td><span id="v55610085" class="anchor"></span><div class="para"> <p> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="b2855c83-a53a-484a-812f-7e0dac3a6534" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">Heart failure</a><span id="b2855c83-a53a-484a-812f-7e0dac3a6534" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v55610089" class="anchor"></span><div class="para"> <p>Immobilization/reduced mobility (eg, prolonged car rides, air travel)</p></div></td></tr><tr class="even"><td><span id="v55610092" class="anchor"></span><div class="para"> <p>Indwelling venous catheters</p></div></td></tr><tr class="odd"><td><span id="v55610095" class="anchor"></span><div class="para"> <p>Infection (ie, as a cause of immobility and systemic inflammatory response; <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html" data-toggle="tooltip" title="COVID-19" data-id="14e71390-e012-4e3d-a54a-daaef9cddf0d" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">SARS-CoV-2</a><span id="14e71390-e012-4e3d-a54a-daaef9cddf0d" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> COVID-19 </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> appears prothrombotic)</p></div></td></tr><tr class="even"><td><span id="v55610099" class="anchor"></span><div class="para"> <p> <a href="./{6F0F2AEE-EEA7-494D-9A62-A001CC0C2D33}.html" data-toggle="tooltip" title="Overview of Nephrotic Syndrome" data-id="1e8ffef6-1d6d-483f-8e07-ea34167a7b39" data-itemid="6f0f2aee-eea7-494d-9a62-a001cc0c2d33">Nephrotic syndrome</a><span id="1e8ffef6-1d6d-483f-8e07-ea34167a7b39" class="d-none xref"> <span class="tooltip-container"> <a href="./{6F0F2AEE-EEA7-494D-9A62-A001CC0C2D33}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Nephrotic Syndrome </span> Nephrotic syndrome is urinary excretion of > 3 g of protein/day due to a glomerular disorder plus edema and hypoalbuminemia. It is more common among children and has both primary and secondary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v55610103" class="anchor"></span><div class="para"> <p> <a href="./{AD52F309-4708-4598-8817-96D23E83F25F}.html" data-toggle="tooltip" title="Obesity" data-id="96b15f67-1f94-4ecc-b4ec-44709ae485fb" data-itemid="ad52f309-4708-4598-8817-96d23e83f25f">Obesity</a><span id="96b15f67-1f94-4ecc-b4ec-44709ae485fb" class="d-none xref"> <span class="tooltip-container"> <a href="./{AD52F309-4708-4598-8817-96D23E83F25F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Obesity </span> Obesity is a chronic, multifactorial, relapsing disorder characterized by excess body weight and defined as a body mass index (BMI) of ≥ 30 kg/m2. Complications include cardiovascular disorders... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v55610107" class="anchor"></span><div class="para"> <p>Pregnancy/postpartum period </p></div></td></tr><tr class="odd"><td><span id="v55610110" class="anchor"></span><div class="para"> <p>Prior thromboembolism</p></div></td></tr><tr class="even"><td><span id="v55610113" class="anchor"></span><div class="para"> <p> <a href="./{7BC15747-85EC-4626-B72A-56C6C28000B8}.html" data-toggle="tooltip" title="Sickle Cell Disease" data-id="271aa395-2456-476a-bb3b-5ff26c0abcad" data-itemid="7bc15747-85ec-4626-b72a-56c6c28000b8">Sickle cell disease</a><span id="271aa395-2456-476a-bb3b-5ff26c0abcad" class="d-none xref"> <span class="tooltip-container"> <a href="./{7BC15747-85EC-4626-B72A-56C6C28000B8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sickle Cell Disease </span> Sickle cell disease (a hemoglobinopathy) causes a chronic hemolytic anemia occurring almost exclusively in people with African ancestry. It is caused by homozygous inheritance of genes for hemoglobin... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/s/i/c/sickle_cells_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Sickle Cell Disease" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v55610117" class="anchor"></span><div class="para"> <p>Smoking</p></div></td></tr><tr class="even"><td><span id="v55610120" class="anchor"></span><div class="para"> <p> <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html" data-toggle="tooltip" title="Overview of Stroke" data-id="8a42a500-cbc9-4df6-85ff-f784a35b9468" data-itemid="e61c2983-3440-4f96-aa2e-b108231a4e5d">Stroke</a><span id="8a42a500-cbc9-4df6-85ff-f784a35b9468" class="d-none xref"> <span class="tooltip-container"> <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Stroke </span> Strokes are a heterogeneous group of disorders involving sudden, focal interruption of cerebral blood flow that causes neurologic deficit. Strokes can be Ischemic (80%), typically resulting... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/s/u/b/subacute-mca-infarct-ctisus-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Stroke" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v55610124" class="anchor"></span><div class="para"> <p>Thrombotic disorders (thrombophilias)</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v55610127" class="anchor"></span><div class="para"> <p> <a href="./{44CEDC40-68D1-4D39-B8AF-97CC5C64D120}.html" data-toggle="tooltip" title="Antiphospholipid Syndrome (APS)" data-id="dfa31e60-95df-45c3-a28d-e2c53a14b4e7" data-itemid="44cedc40-68d1-4d39-b8af-97cc5c64d120">Antiphospholipid syndrome</a><span id="dfa31e60-95df-45c3-a28d-e2c53a14b4e7" class="d-none xref"> <span class="tooltip-container"> <a href="./{44CEDC40-68D1-4D39-B8AF-97CC5C64D120}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiphospholipid Syndrome (APS) </span> Antiphospholipid syndrome is an autoimmune disorder characterized by venous and arterial thrombosis or pregnancy complications (eg, recurrent miscarriage) and persistent autoantibodies to phospholipid-bound... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610130" class="anchor"></span><div class="para"> <p> <a href="./{D55E1ACF-89CD-45CE-9A6C-75373F12186A}.html" data-toggle="tooltip" title="Antithrombin Deficiency" data-id="cba65925-2f59-4a84-8536-f946a8d9f8ee" data-itemid="d55e1acf-89cd-45ce-9a6c-75373f12186a">Antithrombin deficiency</a><span id="cba65925-2f59-4a84-8536-f946a8d9f8ee" class="d-none xref"> <span class="tooltip-container"> <a href="./{D55E1ACF-89CD-45CE-9A6C-75373F12186A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antithrombin Deficiency </span> Because antithrombin inhibits thrombin and factors Xa, IXa, and XIa, deficiency of antithrombin predisposes to venous thrombosis. (See also Overview of Thrombotic Disorders.) Antithrombin is... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610132" class="anchor"></span><div class="para"> <p> <a href="./{D509DE60-69ED-4AAD-9E78-1D1840E158F3}.html" data-toggle="tooltip" title="Factor V Resistance to Activated Protein C (APC)" data-id="98ee310c-e612-4969-a2bb-f7504878a3b5" data-itemid="d509de60-69ed-4aad-9e78-1d1840e158f3">Factor V Leiden mutation</a><span id="98ee310c-e612-4969-a2bb-f7504878a3b5" class="d-none xref"> <span class="tooltip-container"> <a href="./{D509DE60-69ED-4AAD-9E78-1D1840E158F3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Factor V Resistance to Activated Protein C (APC) </span> Mutations of factor V make it resistant to its normal cleavage and inactivation by activated protein C, and they also predispose to venous thrombosis. (See also Overview of Thrombotic Disorders... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (activated protein C resistance)</p></div></li><li class="topic__listitem"><span id="v55610135" class="anchor"></span><div class="para"> <p> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="562f2fc4-d378-4d57-9586-c493df7ea2e1" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Heparin</span>-induced thrombocytopenia</a><span id="562f2fc4-d378-4d57-9586-c493df7ea2e1" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610138" class="anchor"></span><div class="para"> <p>Hereditary fibrinolytic defects </p></div></li><li class="topic__listitem"><span id="v55610140" class="anchor"></span><div class="para"> <p> <a href="./{4AB8034A-CCAB-4E1E-AE47-0377DB2B0278}.html" data-toggle="tooltip" title="Hyperhomocysteinemia" data-id="75c18aaa-2244-4e26-8649-16393a342546" data-itemid="4ab8034a-ccab-4e1e-ae47-0377db2b0278">Hyperhomocystinemia</a><span id="75c18aaa-2244-4e26-8649-16393a342546" class="d-none xref"> <span class="tooltip-container"> <a href="./{4AB8034A-CCAB-4E1E-AE47-0377DB2B0278}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyperhomocysteinemia </span> Hyperhomocysteinemia may predispose to arterial and venous thrombosis. (See also Overview of Thrombotic Disorders.) Hyperhomocysteinemia may predispose to arterial thrombosis and venous thromboembolism... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610143" class="anchor"></span><div class="para"> <p> <a href="./{C8C63FEB-DAAB-4825-BC7B-BC01B3528CF4}.html" data-toggle="tooltip" title="Von Willebrand Disease" data-id="675900cc-48ad-4a4e-9c97-6473f751a406" data-itemid="c8c63feb-daab-4825-bc7b-bc01b3528cf4">Increase in factor VIII levels</a><span id="675900cc-48ad-4a4e-9c97-6473f751a406" class="d-none xref"> <span class="tooltip-container"> <a href="./{C8C63FEB-DAAB-4825-BC7B-BC01B3528CF4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Von Willebrand Disease </span> Von Willebrand disease (VWD) is a hereditary quantitative deficiency or functional abnormality of von Willebrand factor (VWF), which causes platelet dysfunction. Bleeding tendency is usually... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610145" class="anchor"></span><div class="para"> <p> <a href="./{C8C63FEB-DAAB-4825-BC7B-BC01B3528CF4}.html" data-toggle="tooltip" title="Von Willebrand Disease" data-id="4f0fd0c0-22fa-4ecb-b93a-e32acfd44a3f" data-itemid="c8c63feb-daab-4825-bc7b-bc01b3528cf4">Increase in factor XI levels</a><span id="4f0fd0c0-22fa-4ecb-b93a-e32acfd44a3f" class="d-none xref"> <span class="tooltip-container"> <a href="./{C8C63FEB-DAAB-4825-BC7B-BC01B3528CF4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Von Willebrand Disease </span> Von Willebrand disease (VWD) is a hereditary quantitative deficiency or functional abnormality of von Willebrand factor (VWF), which causes platelet dysfunction. Bleeding tendency is usually... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610147" class="anchor"></span><div class="para"> <p>Increase in <span class="genericDrug" data-showrollover="false">von Willebrand factor</span> levels</p></div></li><li class="topic__listitem"><span id="v55610149" class="anchor"></span><div class="para"> <p> <a href="./{A180CFCA-0483-4531-AA50-8237909E35E8}.html" data-toggle="tooltip" title="Paroxysmal Nocturnal Hemoglobinuria (PNH)" data-id="2aa72b16-2854-4099-b5fd-da53571cd0b5" data-itemid="a180cfca-0483-4531-aa50-8237909e35e8">Paroxysmal nocturnal hemoglobinuria</a><span id="2aa72b16-2854-4099-b5fd-da53571cd0b5" class="d-none xref"> <span class="tooltip-container"> <a href="./{A180CFCA-0483-4531-AA50-8237909E35E8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Paroxysmal Nocturnal Hemoglobinuria (PNH) </span> Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder characterized by intravascular hemolysis and hemoglobinuria. Leukopenia, thrombocytopenia, arterial and venous thromboses... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610152" class="anchor"></span><div class="para"> <p> <a href="./{9C575C78-50DE-4E82-A630-2B8FD6D5F283}.html" data-toggle="tooltip" title="Protein C Deficiency" data-id="e404fce1-3e08-419b-98bc-3f83c6ec206f" data-itemid="9c575c78-50de-4e82-a630-2b8fd6d5f283">Protein C deficiency</a><span id="e404fce1-3e08-419b-98bc-3f83c6ec206f" class="d-none xref"> <span class="tooltip-container"> <a href="./{9C575C78-50DE-4E82-A630-2B8FD6D5F283}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Protein C Deficiency </span> Because activated protein C degrades coagulation factors Va and VIIIa, deficiency of protein C predisposes to venous thrombosis. (See also Overview of Thrombotic Disorders.) Protein C is a vitamin... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610155" class="anchor"></span><div class="para"> <p> <a href="./{BB2C9709-6481-457C-8632-F9ABAF438A8B}.html" data-toggle="tooltip" title="Protein S Deficiency" data-id="59f25ef4-8a09-47ec-89af-bccf735e1c41" data-itemid="bb2c9709-6481-457c-8632-f9abaf438a8b">Protein S deficiency</a><span id="59f25ef4-8a09-47ec-89af-bccf735e1c41" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB2C9709-6481-457C-8632-F9ABAF438A8B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Protein S Deficiency </span> Because protein S binds and assists activated protein C in the degradation of coagulation factors Va and VIIIa, deficiency of protein S predisposes to venous thrombosis. (See also Overview of... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610158" class="anchor"></span><div class="para"> <p> <a href="./{B79A7A4E-F9FE-4A4A-9402-BE0704E3D32B}.html" data-toggle="tooltip" title="Prothrombin (Factor II) 20210 Gene Mutation" data-id="a558c7ad-00a7-48dc-b00b-063217f15d41" data-itemid="b79a7a4e-f9fe-4a4a-9402-be0704e3d32b">Prothrombin G20210A gene variant</a><span id="a558c7ad-00a7-48dc-b00b-063217f15d41" class="d-none xref"> <span class="tooltip-container"> <a href="./{B79A7A4E-F9FE-4A4A-9402-BE0704E3D32B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Prothrombin (Factor II) 20210 Gene Mutation </span> A genetic mutation causes increased plasma levels of prothrombin (factor II), predisposing to venous thrombosis. (See also Overview of Thrombotic Disorders.) Prothrombin (factor II) is a vitamin... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610161" class="anchor"></span><div class="para"> <p>Tissue factor pathway inhibitor deficiency or impaired function</p></div></li></ul></div></td></tr><tr class="even"><td><span id="v55610164" class="anchor"></span><div class="para"> <p>Trauma/surgery </p></div></td></tr><tr class="odd"><td><span id="v55610167" class="anchor"></span><div class="para"> <p>Other conditions associated with reduced mobility, venous injury, or hypercoagulability</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55610056'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v915358"></span> <div class="TableHalfPage" id="v55610056"> <h3 class="title">Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><span id="v55610063" class="anchor"></span><div class="para"> <p>Age > 60 years</p></div></td></tr><tr class="even"><td><span id="v55610066" class="anchor"></span><div class="para"> <p>Cancer and <a href="./{03CAB393-E97F-43C1-ACFF-2A01DB295336}.html" data-toggle="tooltip" title="Overview of Myeloproliferative Neoplasms" data-id="295a3b2f-bc5b-4f4b-a3e2-4c29b08f9348" data-itemid="03cab393-e97f-43c1-acff-2a01db295336">myeloproliferative neoplasms</a><span id="295a3b2f-bc5b-4f4b-a3e2-4c29b08f9348" class="d-none xref"> <span class="tooltip-container"> <a href="./{03CAB393-E97F-43C1-ACFF-2A01DB295336}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Myeloproliferative Neoplasms </span> Myeloproliferative neoplasms are clonal proliferations of bone marrow hematopoietic stem cells, which can manifest as an increased number of functionally normal platelets, red blood cells (RBCs)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div><span id="v55610068" class="anchor"></span><div class="para"> <p>Certain chemotherapeutic agents (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>thalidomide</span>)</p></div></td></tr><tr class="odd"><td><span id="v55610071" class="anchor"></span><div class="para"> <p>Hormonal modulation </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v55610074" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Estrogen</span> receptor modulators (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span>)</p></div></li><li class="topic__listitem"><span id="v55610077" class="anchor"></span><div class="para"> <p>Exogenous <span class="genericDrug" data-showrollover="false">estrogens</span> and progestins, including oral contraceptives and <span class="genericDrug" data-showrollover="false">estrogen</span> therapy </p></div></li><li class="topic__listitem"><span id="v55610081" class="anchor"></span><div class="para"> <p>Exogenous <span class="genericDrug" data-showrollover="false">testosterone</span></p></div></li></ul></div></td></tr><tr class="even"><td><span id="v55610085" class="anchor"></span><div class="para"> <p> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="b2855c83-a53a-484a-812f-7e0dac3a6534" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">Heart failure</a><span id="b2855c83-a53a-484a-812f-7e0dac3a6534" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v55610089" class="anchor"></span><div class="para"> <p>Immobilization/reduced mobility (eg, prolonged car rides, air travel)</p></div></td></tr><tr class="even"><td><span id="v55610092" class="anchor"></span><div class="para"> <p>Indwelling venous catheters</p></div></td></tr><tr class="odd"><td><span id="v55610095" class="anchor"></span><div class="para"> <p>Infection (ie, as a cause of immobility and systemic inflammatory response; <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html" data-toggle="tooltip" title="COVID-19" data-id="14e71390-e012-4e3d-a54a-daaef9cddf0d" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">SARS-CoV-2</a><span id="14e71390-e012-4e3d-a54a-daaef9cddf0d" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> COVID-19 </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> appears prothrombotic)</p></div></td></tr><tr class="even"><td><span id="v55610099" class="anchor"></span><div class="para"> <p> <a href="./{6F0F2AEE-EEA7-494D-9A62-A001CC0C2D33}.html" data-toggle="tooltip" title="Overview of Nephrotic Syndrome" data-id="1e8ffef6-1d6d-483f-8e07-ea34167a7b39" data-itemid="6f0f2aee-eea7-494d-9a62-a001cc0c2d33">Nephrotic syndrome</a><span id="1e8ffef6-1d6d-483f-8e07-ea34167a7b39" class="d-none xref"> <span class="tooltip-container"> <a href="./{6F0F2AEE-EEA7-494D-9A62-A001CC0C2D33}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Nephrotic Syndrome </span> Nephrotic syndrome is urinary excretion of > 3 g of protein/day due to a glomerular disorder plus edema and hypoalbuminemia. It is more common among children and has both primary and secondary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v55610103" class="anchor"></span><div class="para"> <p> <a href="./{AD52F309-4708-4598-8817-96D23E83F25F}.html" data-toggle="tooltip" title="Obesity" data-id="96b15f67-1f94-4ecc-b4ec-44709ae485fb" data-itemid="ad52f309-4708-4598-8817-96d23e83f25f">Obesity</a><span id="96b15f67-1f94-4ecc-b4ec-44709ae485fb" class="d-none xref"> <span class="tooltip-container"> <a href="./{AD52F309-4708-4598-8817-96D23E83F25F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Obesity </span> Obesity is a chronic, multifactorial, relapsing disorder characterized by excess body weight and defined as a body mass index (BMI) of ≥ 30 kg/m2. Complications include cardiovascular disorders... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v55610107" class="anchor"></span><div class="para"> <p>Pregnancy/postpartum period </p></div></td></tr><tr class="odd"><td><span id="v55610110" class="anchor"></span><div class="para"> <p>Prior thromboembolism</p></div></td></tr><tr class="even"><td><span id="v55610113" class="anchor"></span><div class="para"> <p> <a href="./{7BC15747-85EC-4626-B72A-56C6C28000B8}.html" data-toggle="tooltip" title="Sickle Cell Disease" data-id="271aa395-2456-476a-bb3b-5ff26c0abcad" data-itemid="7bc15747-85ec-4626-b72a-56c6c28000b8">Sickle cell disease</a><span id="271aa395-2456-476a-bb3b-5ff26c0abcad" class="d-none xref"> <span class="tooltip-container"> <a href="./{7BC15747-85EC-4626-B72A-56C6C28000B8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sickle Cell Disease </span> Sickle cell disease (a hemoglobinopathy) causes a chronic hemolytic anemia occurring almost exclusively in people with African ancestry. It is caused by homozygous inheritance of genes for hemoglobin... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/s/i/c/sickle_cells_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Sickle Cell Disease" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v55610117" class="anchor"></span><div class="para"> <p>Smoking</p></div></td></tr><tr class="even"><td><span id="v55610120" class="anchor"></span><div class="para"> <p> <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html" data-toggle="tooltip" title="Overview of Stroke" data-id="8a42a500-cbc9-4df6-85ff-f784a35b9468" data-itemid="e61c2983-3440-4f96-aa2e-b108231a4e5d">Stroke</a><span id="8a42a500-cbc9-4df6-85ff-f784a35b9468" class="d-none xref"> <span class="tooltip-container"> <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Stroke </span> Strokes are a heterogeneous group of disorders involving sudden, focal interruption of cerebral blood flow that causes neurologic deficit. Strokes can be Ischemic (80%), typically resulting... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/s/u/b/subacute-mca-infarct-ctisus-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Stroke" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v55610124" class="anchor"></span><div class="para"> <p>Thrombotic disorders (thrombophilias)</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v55610127" class="anchor"></span><div class="para"> <p> <a href="./{44CEDC40-68D1-4D39-B8AF-97CC5C64D120}.html" data-toggle="tooltip" title="Antiphospholipid Syndrome (APS)" data-id="dfa31e60-95df-45c3-a28d-e2c53a14b4e7" data-itemid="44cedc40-68d1-4d39-b8af-97cc5c64d120">Antiphospholipid syndrome</a><span id="dfa31e60-95df-45c3-a28d-e2c53a14b4e7" class="d-none xref"> <span class="tooltip-container"> <a href="./{44CEDC40-68D1-4D39-B8AF-97CC5C64D120}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiphospholipid Syndrome (APS) </span> Antiphospholipid syndrome is an autoimmune disorder characterized by venous and arterial thrombosis or pregnancy complications (eg, recurrent miscarriage) and persistent autoantibodies to phospholipid-bound... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610130" class="anchor"></span><div class="para"> <p> <a href="./{D55E1ACF-89CD-45CE-9A6C-75373F12186A}.html" data-toggle="tooltip" title="Antithrombin Deficiency" data-id="cba65925-2f59-4a84-8536-f946a8d9f8ee" data-itemid="d55e1acf-89cd-45ce-9a6c-75373f12186a">Antithrombin deficiency</a><span id="cba65925-2f59-4a84-8536-f946a8d9f8ee" class="d-none xref"> <span class="tooltip-container"> <a href="./{D55E1ACF-89CD-45CE-9A6C-75373F12186A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antithrombin Deficiency </span> Because antithrombin inhibits thrombin and factors Xa, IXa, and XIa, deficiency of antithrombin predisposes to venous thrombosis. (See also Overview of Thrombotic Disorders.) Antithrombin is... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610132" class="anchor"></span><div class="para"> <p> <a href="./{D509DE60-69ED-4AAD-9E78-1D1840E158F3}.html" data-toggle="tooltip" title="Factor V Resistance to Activated Protein C (APC)" data-id="98ee310c-e612-4969-a2bb-f7504878a3b5" data-itemid="d509de60-69ed-4aad-9e78-1d1840e158f3">Factor V Leiden mutation</a><span id="98ee310c-e612-4969-a2bb-f7504878a3b5" class="d-none xref"> <span class="tooltip-container"> <a href="./{D509DE60-69ED-4AAD-9E78-1D1840E158F3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Factor V Resistance to Activated Protein C (APC) </span> Mutations of factor V make it resistant to its normal cleavage and inactivation by activated protein C, and they also predispose to venous thrombosis. (See also Overview of Thrombotic Disorders... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (activated protein C resistance)</p></div></li><li class="topic__listitem"><span id="v55610135" class="anchor"></span><div class="para"> <p> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="562f2fc4-d378-4d57-9586-c493df7ea2e1" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Heparin</span>-induced thrombocytopenia</a><span id="562f2fc4-d378-4d57-9586-c493df7ea2e1" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610138" class="anchor"></span><div class="para"> <p>Hereditary fibrinolytic defects </p></div></li><li class="topic__listitem"><span id="v55610140" class="anchor"></span><div class="para"> <p> <a href="./{4AB8034A-CCAB-4E1E-AE47-0377DB2B0278}.html" data-toggle="tooltip" title="Hyperhomocysteinemia" data-id="75c18aaa-2244-4e26-8649-16393a342546" data-itemid="4ab8034a-ccab-4e1e-ae47-0377db2b0278">Hyperhomocystinemia</a><span id="75c18aaa-2244-4e26-8649-16393a342546" class="d-none xref"> <span class="tooltip-container"> <a href="./{4AB8034A-CCAB-4E1E-AE47-0377DB2B0278}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyperhomocysteinemia </span> Hyperhomocysteinemia may predispose to arterial and venous thrombosis. (See also Overview of Thrombotic Disorders.) Hyperhomocysteinemia may predispose to arterial thrombosis and venous thromboembolism... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610143" class="anchor"></span><div class="para"> <p> <a href="./{C8C63FEB-DAAB-4825-BC7B-BC01B3528CF4}.html" data-toggle="tooltip" title="Von Willebrand Disease" data-id="675900cc-48ad-4a4e-9c97-6473f751a406" data-itemid="c8c63feb-daab-4825-bc7b-bc01b3528cf4">Increase in factor VIII levels</a><span id="675900cc-48ad-4a4e-9c97-6473f751a406" class="d-none xref"> <span class="tooltip-container"> <a href="./{C8C63FEB-DAAB-4825-BC7B-BC01B3528CF4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Von Willebrand Disease </span> Von Willebrand disease (VWD) is a hereditary quantitative deficiency or functional abnormality of von Willebrand factor (VWF), which causes platelet dysfunction. Bleeding tendency is usually... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610145" class="anchor"></span><div class="para"> <p> <a href="./{C8C63FEB-DAAB-4825-BC7B-BC01B3528CF4}.html" data-toggle="tooltip" title="Von Willebrand Disease" data-id="4f0fd0c0-22fa-4ecb-b93a-e32acfd44a3f" data-itemid="c8c63feb-daab-4825-bc7b-bc01b3528cf4">Increase in factor XI levels</a><span id="4f0fd0c0-22fa-4ecb-b93a-e32acfd44a3f" class="d-none xref"> <span class="tooltip-container"> <a href="./{C8C63FEB-DAAB-4825-BC7B-BC01B3528CF4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Von Willebrand Disease </span> Von Willebrand disease (VWD) is a hereditary quantitative deficiency or functional abnormality of von Willebrand factor (VWF), which causes platelet dysfunction. Bleeding tendency is usually... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610147" class="anchor"></span><div class="para"> <p>Increase in <span class="genericDrug" data-showrollover="false">von Willebrand factor</span> levels</p></div></li><li class="topic__listitem"><span id="v55610149" class="anchor"></span><div class="para"> <p> <a href="./{A180CFCA-0483-4531-AA50-8237909E35E8}.html" data-toggle="tooltip" title="Paroxysmal Nocturnal Hemoglobinuria (PNH)" data-id="2aa72b16-2854-4099-b5fd-da53571cd0b5" data-itemid="a180cfca-0483-4531-aa50-8237909e35e8">Paroxysmal nocturnal hemoglobinuria</a><span id="2aa72b16-2854-4099-b5fd-da53571cd0b5" class="d-none xref"> <span class="tooltip-container"> <a href="./{A180CFCA-0483-4531-AA50-8237909E35E8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Paroxysmal Nocturnal Hemoglobinuria (PNH) </span> Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder characterized by intravascular hemolysis and hemoglobinuria. Leukopenia, thrombocytopenia, arterial and venous thromboses... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610152" class="anchor"></span><div class="para"> <p> <a href="./{9C575C78-50DE-4E82-A630-2B8FD6D5F283}.html" data-toggle="tooltip" title="Protein C Deficiency" data-id="e404fce1-3e08-419b-98bc-3f83c6ec206f" data-itemid="9c575c78-50de-4e82-a630-2b8fd6d5f283">Protein C deficiency</a><span id="e404fce1-3e08-419b-98bc-3f83c6ec206f" class="d-none xref"> <span class="tooltip-container"> <a href="./{9C575C78-50DE-4E82-A630-2B8FD6D5F283}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Protein C Deficiency </span> Because activated protein C degrades coagulation factors Va and VIIIa, deficiency of protein C predisposes to venous thrombosis. (See also Overview of Thrombotic Disorders.) Protein C is a vitamin... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610155" class="anchor"></span><div class="para"> <p> <a href="./{BB2C9709-6481-457C-8632-F9ABAF438A8B}.html" data-toggle="tooltip" title="Protein S Deficiency" data-id="59f25ef4-8a09-47ec-89af-bccf735e1c41" data-itemid="bb2c9709-6481-457c-8632-f9abaf438a8b">Protein S deficiency</a><span id="59f25ef4-8a09-47ec-89af-bccf735e1c41" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB2C9709-6481-457C-8632-F9ABAF438A8B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Protein S Deficiency </span> Because protein S binds and assists activated protein C in the degradation of coagulation factors Va and VIIIa, deficiency of protein S predisposes to venous thrombosis. (See also Overview of... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610158" class="anchor"></span><div class="para"> <p> <a href="./{B79A7A4E-F9FE-4A4A-9402-BE0704E3D32B}.html" data-toggle="tooltip" title="Prothrombin (Factor II) 20210 Gene Mutation" data-id="a558c7ad-00a7-48dc-b00b-063217f15d41" data-itemid="b79a7a4e-f9fe-4a4a-9402-be0704e3d32b">Prothrombin G20210A gene variant</a><span id="a558c7ad-00a7-48dc-b00b-063217f15d41" class="d-none xref"> <span class="tooltip-container"> <a href="./{B79A7A4E-F9FE-4A4A-9402-BE0704E3D32B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Prothrombin (Factor II) 20210 Gene Mutation </span> A genetic mutation causes increased plasma levels of prothrombin (factor II), predisposing to venous thrombosis. (See also Overview of Thrombotic Disorders.) Prothrombin (factor II) is a vitamin... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v55610161" class="anchor"></span><div class="para"> <p>Tissue factor pathway inhibitor deficiency or impaired function</p></div></li></ul></div></td></tr><tr class="even"><td><span id="v55610164" class="anchor"></span><div class="para"> <p>Trauma/surgery </p></div></td></tr><tr class="odd"><td><span id="v55610167" class="anchor"></span><div class="para"> <p>Other conditions associated with reduced mobility, venous injury, or hypercoagulability</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55610275'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464272"></span> <div class="TableFullPage" id="v55610275"> <h3 class="title">Oral Anticoagulants</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610284" class="anchor"></span><div class="para"> <p>Drug</p></div></th><th style='text-align:left' scope='col'><span id="v55610288" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610293" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitors</p></div></p></td></tr><tr class="even"><td><span id="v55610296" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span></p></div></td><td><span id="v55610301" class="anchor"></span><div class="para"> <p>Dosage may be lowered after 6–12 months of treatment.</p></div></td></tr><tr class="odd"><td><span id="v55610304" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span></p></div></td><td><span id="v55610309" class="anchor"></span><div class="para"> <p>Initial treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5–10 days.</p></div><span id="v55610310" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span> should not be used if creatinine clearance is < 15="" ml/minute=""><span class='symbol'></span> 0.25 mL/second).</p></div></td></tr><tr class="even"><td><span id="v55610313" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span></p></div></td><td><span id="v55610318" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span> should not be used for DVT or PE if creatinine clearance is < 30="" ml/minute="">< 0.5="" ml/second).=""></p></div><span id="v55610319" class="anchor"></span><div class="para"> <p>Dosage may be lowered to 10 mg once/day after 6–12 months of treatment.</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610323" class="anchor"></span><div class="para"> <p>Factor IIa (<span class="genericDrug" data-showrollover="false">thrombin</span>) inhibitor</p></div></p></td></tr><tr class="even"><td><span id="v55610326" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span></p></div></td><td><span id="v55610330" class="anchor"></span><div class="para"> <p>Initial treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5–10 days.</p></div><span id="v55610331" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span> should not be used for DVT if creatinine clearance is < 30=""></p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55610370'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464510"></span> <div class="TableFullPage" id="v55610370"> <h3 class="title">Risk Assessment for Thrombosis</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610378" class="anchor"></span><div class="para"> <p>Risk Factor</p></div></th><th style='text-align:left' scope='col'><span id="v55610380" class="anchor"></span><div class="para"> <p>Score</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610403" class="anchor"></span><div class="para"> <p>Age (years)</p></div></p></td></tr><tr class="even"><td><span id="v55610406" class="anchor"></span><div class="para"> <p>41–60</p></div></td><td><span id="v55610408" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610411" class="anchor"></span><div class="para"> <p>60–74</p></div></td><td><span id="v55610413" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610416" class="anchor"></span><div class="para"> <p>≥ 75</p></div></td><td><span id="v55610418" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610422" class="anchor"></span><div class="para"> <p>Surgery</p></div></p></td></tr><tr class="even"><td><span id="v55610425" class="anchor"></span><div class="para"> <p>Minor surgery during current hospitalization</p></div></td><td><span id="v55610427" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610430" class="anchor"></span><div class="para"> <p> Major surgery within the past 1 month </p></div></td><td><span id="v55610432" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610435" class="anchor"></span><div class="para"> <p>Arthroscopic surgery during current hospitalization</p></div></td><td><span id="v55610437" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610440" class="anchor"></span><div class="para"> <p>Major surgery lasting > 45 minutes during current hospitalization</p></div></td><td><span id="v55610442" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610445" class="anchor"></span><div class="para"> <p>Laparoscopic surgery lasting > 45 minutes during current hospitalization</p></div></td><td><span id="v55610447" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610450" class="anchor"></span><div class="para"> <p>Elective major arthroplasty of the leg during current hospitalization</p></div></td><td><span id="v55610452" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610456" class="anchor"></span><div class="para"> <p>Coexisting conditions</p></div></p></td></tr><tr class="odd"><td><span id="v55610459" class="anchor"></span><div class="para"> <p>Varicose veins</p></div></td><td><span id="v55610461" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610464" class="anchor"></span><div class="para"> <p>Inflammatory bowel disease</p></div></td><td><span id="v55610466" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610469" class="anchor"></span><div class="para"> <p>Edema, leg (current)</p></div></td><td><span id="v55610471" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610474" class="anchor"></span><div class="para"> <p>Obesity (BMI > 25)</p></div></td><td><span id="v55610476" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610479" class="anchor"></span><div class="para"> <p>Acute myocardial infarction</p></div></td><td><span id="v55610481" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610484" class="anchor"></span><div class="para"> <p>Heart failure within the preceding 1 month</p></div></td><td><span id="v55610486" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610489" class="anchor"></span><div class="para"> <p>Sepsis within the preceding 1 month</p></div></td><td><span id="v55610491" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610494" class="anchor"></span><div class="para"> <p>Serious lung disease* within the preceding 1 month</p></div></td><td><span id="v55610496" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610499" class="anchor"></span><div class="para"> <p>Abnormal pulmonary function (eg, COPD)</p></div></td><td><span id="v55610501" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610504" class="anchor"></span><div class="para"> <p>Central venous access</p></div></td><td><span id="v55610506" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610509" class="anchor"></span><div class="para"> <p>Cancer (present or previous)</p></div></td><td><span id="v55610511" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610514" class="anchor"></span><div class="para"> <p>History of DVT/PE</p></div></td><td><span id="v55610516" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610519" class="anchor"></span><div class="para"> <p>Family history of thrombosis†</p></div></td><td><span id="v55610521" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610524" class="anchor"></span><div class="para"> <p>Factor V Leiden mutation</p></div></td><td><span id="v55610526" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610529" class="anchor"></span><div class="para"> <p>Prothrombin 20210A mutation</p></div></td><td><span id="v55610531" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610534" class="anchor"></span><div class="para"> <p>Elevated serum homocysteine</p></div></td><td><span id="v55610536" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610539" class="anchor"></span><div class="para"> <p>Positive lupus anticoagulant</p></div></td><td><span id="v55610541" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610544" class="anchor"></span><div class="para"> <p>Elevated anticardiolipin antibodies</p></div></td><td><span id="v55610546" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610549" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Heparin</span>-induced thrombocytopenia</p></div></td><td><span id="v55610551" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610554" class="anchor"></span><div class="para"> <p>Other congenital or acquired thrombophilia</p></div></td><td><span id="v55610556" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610559" class="anchor"></span><div class="para"> <p>Stroke within the preceding 1 month</p></div></td><td><span id="v55610561" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even"><td><span id="v55610564" class="anchor"></span><div class="para"> <p>Multiple trauma within the preceding 1 month </p></div></td><td><span id="v55610566" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="odd"><td><span id="v55610569" class="anchor"></span><div class="para"> <p>Acute spinal cord injury/paralysis within the preceding 1 month</p></div></td><td><span id="v55610571" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610575" class="anchor"></span><div class="para"> <p>Immobilization</p></div></p></td></tr><tr class="odd"><td><span id="v55610578" class="anchor"></span><div class="para"> <p>Current bed rest (medical patient)</p></div></td><td><span id="v55610580" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610583" class="anchor"></span><div class="para"> <p>Bed rest > 72 hours</p></div></td><td><span id="v55610585" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610588" class="anchor"></span><div class="para"> <p>Immobilizing plaster cast within the preceding 1 month</p></div></td><td><span id="v55610590" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610593" class="anchor"></span><div class="para"> <p>Hip, pelvis, or leg fracture within the preceding 1 month</p></div></td><td><span id="v55610595" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610599" class="anchor"></span><div class="para"> <p>Additional risk factors for women</p></div></p></td></tr><tr class="even"><td><span id="v55610602" class="anchor"></span><div class="para"> <p>Oral contraceptive use or hormone replacement therapy</p></div></td><td><span id="v55610604" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610607" class="anchor"></span><div class="para"> <p>Pregnancy or postpartum within the preceding 1 month</p></div></td><td><span id="v55610609" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610612" class="anchor"></span><div class="para"> <p>History of unexplained stillbirth, recurrent spontaneous abortion (≥ 3), premature birth with toxemia or growth-restricted infant</p></div></td><td><span id="v55610614" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610618" class="anchor"></span><div class="para"> <p>Other</p></div></p></td></tr><tr class="even"><td><span id="v55610621" class="anchor"></span><div class="para"> <p>Other risk factors‡</p></div></td><td><span id="v55610623" class="anchor"></span><div class="para"> <p>1</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v55610384" class="anchor"></span><div class="para"> <p>* Serious lung disease includes pneumonia.</p></div></td></tr><tr><td colspan="2"><span id="v55610387" class="anchor"></span><div class="para"> <p>† Family history of thrombosis is the most frequently missed risk factor.</p></div></td></tr><tr><td colspan="2"><span id="v55610390" class="anchor"></span><div class="para"> <p>‡ Other risk factors include BMI > 40, smoking, diabetes requiring <span class="genericDrug" data-showrollover="false">insulin</span> therapy, chemotherapy, blood transfusions, and length of surgery > 2 hours.</p></div></td></tr><tr><td colspan="2"><span id="v55610394" class="anchor"></span><div class="para"> <p>Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/22315263/">Gould MK, Garcia DA, Wren SM, et al</a>. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published correction appears in <i>Chest</i> 2012 May;141(5):1369]. <i>Chest</i> 2012;141(2 Suppl):e227S-e277S. doi:10.1378/chest.11-2297</p></div></td></tr><tr><td colspan="2"><span id="v55610398" class="anchor"></span><div class="para"> <p>BMI = body mass index; COPD = chronic obstructive pulmonary disease; DVT = deep vein thrombosis; PE = pulmonary embolism.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55610370'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464510"></span> <div class="TableFullPage" id="v55610370"> <h3 class="title">Risk Assessment for Thrombosis</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610378" class="anchor"></span><div class="para"> <p>Risk Factor</p></div></th><th style='text-align:left' scope='col'><span id="v55610380" class="anchor"></span><div class="para"> <p>Score</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610403" class="anchor"></span><div class="para"> <p>Age (years)</p></div></p></td></tr><tr class="even"><td><span id="v55610406" class="anchor"></span><div class="para"> <p>41–60</p></div></td><td><span id="v55610408" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610411" class="anchor"></span><div class="para"> <p>60–74</p></div></td><td><span id="v55610413" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610416" class="anchor"></span><div class="para"> <p>≥ 75</p></div></td><td><span id="v55610418" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610422" class="anchor"></span><div class="para"> <p>Surgery</p></div></p></td></tr><tr class="even"><td><span id="v55610425" class="anchor"></span><div class="para"> <p>Minor surgery during current hospitalization</p></div></td><td><span id="v55610427" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610430" class="anchor"></span><div class="para"> <p> Major surgery within the past 1 month </p></div></td><td><span id="v55610432" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610435" class="anchor"></span><div class="para"> <p>Arthroscopic surgery during current hospitalization</p></div></td><td><span id="v55610437" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610440" class="anchor"></span><div class="para"> <p>Major surgery lasting > 45 minutes during current hospitalization</p></div></td><td><span id="v55610442" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610445" class="anchor"></span><div class="para"> <p>Laparoscopic surgery lasting > 45 minutes during current hospitalization</p></div></td><td><span id="v55610447" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610450" class="anchor"></span><div class="para"> <p>Elective major arthroplasty of the leg during current hospitalization</p></div></td><td><span id="v55610452" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610456" class="anchor"></span><div class="para"> <p>Coexisting conditions</p></div></p></td></tr><tr class="odd"><td><span id="v55610459" class="anchor"></span><div class="para"> <p>Varicose veins</p></div></td><td><span id="v55610461" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610464" class="anchor"></span><div class="para"> <p>Inflammatory bowel disease</p></div></td><td><span id="v55610466" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610469" class="anchor"></span><div class="para"> <p>Edema, leg (current)</p></div></td><td><span id="v55610471" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610474" class="anchor"></span><div class="para"> <p>Obesity (BMI > 25)</p></div></td><td><span id="v55610476" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610479" class="anchor"></span><div class="para"> <p>Acute myocardial infarction</p></div></td><td><span id="v55610481" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610484" class="anchor"></span><div class="para"> <p>Heart failure within the preceding 1 month</p></div></td><td><span id="v55610486" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610489" class="anchor"></span><div class="para"> <p>Sepsis within the preceding 1 month</p></div></td><td><span id="v55610491" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610494" class="anchor"></span><div class="para"> <p>Serious lung disease* within the preceding 1 month</p></div></td><td><span id="v55610496" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610499" class="anchor"></span><div class="para"> <p>Abnormal pulmonary function (eg, COPD)</p></div></td><td><span id="v55610501" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610504" class="anchor"></span><div class="para"> <p>Central venous access</p></div></td><td><span id="v55610506" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610509" class="anchor"></span><div class="para"> <p>Cancer (present or previous)</p></div></td><td><span id="v55610511" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610514" class="anchor"></span><div class="para"> <p>History of DVT/PE</p></div></td><td><span id="v55610516" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610519" class="anchor"></span><div class="para"> <p>Family history of thrombosis†</p></div></td><td><span id="v55610521" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610524" class="anchor"></span><div class="para"> <p>Factor V Leiden mutation</p></div></td><td><span id="v55610526" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610529" class="anchor"></span><div class="para"> <p>Prothrombin 20210A mutation</p></div></td><td><span id="v55610531" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610534" class="anchor"></span><div class="para"> <p>Elevated serum homocysteine</p></div></td><td><span id="v55610536" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610539" class="anchor"></span><div class="para"> <p>Positive lupus anticoagulant</p></div></td><td><span id="v55610541" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610544" class="anchor"></span><div class="para"> <p>Elevated anticardiolipin antibodies</p></div></td><td><span id="v55610546" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610549" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Heparin</span>-induced thrombocytopenia</p></div></td><td><span id="v55610551" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even"><td><span id="v55610554" class="anchor"></span><div class="para"> <p>Other congenital or acquired thrombophilia</p></div></td><td><span id="v55610556" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v55610559" class="anchor"></span><div class="para"> <p>Stroke within the preceding 1 month</p></div></td><td><span id="v55610561" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even"><td><span id="v55610564" class="anchor"></span><div class="para"> <p>Multiple trauma within the preceding 1 month </p></div></td><td><span id="v55610566" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="odd"><td><span id="v55610569" class="anchor"></span><div class="para"> <p>Acute spinal cord injury/paralysis within the preceding 1 month</p></div></td><td><span id="v55610571" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610575" class="anchor"></span><div class="para"> <p>Immobilization</p></div></p></td></tr><tr class="odd"><td><span id="v55610578" class="anchor"></span><div class="para"> <p>Current bed rest (medical patient)</p></div></td><td><span id="v55610580" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610583" class="anchor"></span><div class="para"> <p>Bed rest > 72 hours</p></div></td><td><span id="v55610585" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v55610588" class="anchor"></span><div class="para"> <p>Immobilizing plaster cast within the preceding 1 month</p></div></td><td><span id="v55610590" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v55610593" class="anchor"></span><div class="para"> <p>Hip, pelvis, or leg fracture within the preceding 1 month</p></div></td><td><span id="v55610595" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610599" class="anchor"></span><div class="para"> <p>Additional risk factors for women</p></div></p></td></tr><tr class="even"><td><span id="v55610602" class="anchor"></span><div class="para"> <p>Oral contraceptive use or hormone replacement therapy</p></div></td><td><span id="v55610604" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v55610607" class="anchor"></span><div class="para"> <p>Pregnancy or postpartum within the preceding 1 month</p></div></td><td><span id="v55610609" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v55610612" class="anchor"></span><div class="para"> <p>History of unexplained stillbirth, recurrent spontaneous abortion (≥ 3), premature birth with toxemia or growth-restricted infant</p></div></td><td><span id="v55610614" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610618" class="anchor"></span><div class="para"> <p>Other</p></div></p></td></tr><tr class="even"><td><span id="v55610621" class="anchor"></span><div class="para"> <p>Other risk factors‡</p></div></td><td><span id="v55610623" class="anchor"></span><div class="para"> <p>1</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v55610384" class="anchor"></span><div class="para"> <p>* Serious lung disease includes pneumonia.</p></div></td></tr><tr><td colspan="2"><span id="v55610387" class="anchor"></span><div class="para"> <p>† Family history of thrombosis is the most frequently missed risk factor.</p></div></td></tr><tr><td colspan="2"><span id="v55610390" class="anchor"></span><div class="para"> <p>‡ Other risk factors include BMI > 40, smoking, diabetes requiring <span class="genericDrug" data-showrollover="false">insulin</span> therapy, chemotherapy, blood transfusions, and length of surgery > 2 hours.</p></div></td></tr><tr><td colspan="2"><span id="v55610394" class="anchor"></span><div class="para"> <p>Data from <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/22315263/">Gould MK, Garcia DA, Wren SM, et al</a>. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published correction appears in <i>Chest</i> 2012 May;141(5):1369]. <i>Chest</i> 2012;141(2 Suppl):e227S-e277S. doi:10.1378/chest.11-2297</p></div></td></tr><tr><td colspan="2"><span id="v55610398" class="anchor"></span><div class="para"> <p>BMI = body mass index; COPD = chronic obstructive pulmonary disease; DVT = deep vein thrombosis; PE = pulmonary embolism.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55610625'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464768"></span> <div class="TableFullPage" id="v55610625"> <h3 class="title">Prophylaxis Based on Caprini Score</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610634" class="anchor"></span><div class="para"> <p>Points</p></div></th><th style='text-align:left' scope='col'><span id="v55610636" class="anchor"></span><div class="para"> <p>Risk</p></div></th><th style='text-align:left' scope='col'><span id="v55610638" class="anchor"></span><div class="para"> <p>Prophylaxis</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v55610642" class="anchor"></span><div class="para"> <p>0</p></div></td><td><span id="v55610644" class="anchor"></span><div class="para"> <p>Very low</p></div></td><td><span id="v55610646" class="anchor"></span><div class="para"> <p>Early ambulation</p></div></td></tr><tr class="even"><td><span id="v55610649" class="anchor"></span><div class="para"> <p>1–2</p></div></td><td><span id="v55610651" class="anchor"></span><div class="para"> <p>Low</p></div></td><td><span id="v55610653" class="anchor"></span><div class="para"> <p>Sequential compression device (SCD)</p></div></td></tr><tr class="odd"><td><span id="v55610656" class="anchor"></span><div class="para"> <p>3–4</p></div></td><td><span id="v55610658" class="anchor"></span><div class="para"> <p>Moderate</p></div></td><td><span id="v55610660" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Heparin</span> every 8 hours or low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> +/- SCD</p></div></td></tr><tr class="even"><td><span id="v55610663" class="anchor"></span><div class="para"> <p>≥ 5</p></div></td><td><span id="v55610665" class="anchor"></span><div class="para"> <p>High</p></div></td><td><span id="v55610667" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Heparin</span> or low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> + SCD</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>